<div id="page0" style="width:595.3pt;height:793.7pt">
<p style="top:158.5pt;left:32.8pt;line-height:9.8pt"><span style="font-family:AdvOT863180fb,serif;font-size:9.8pt">Review</span></p>
<p style="top:177.2pt;left:32.8pt;line-height:13.7pt"><span style="font-family:AdvOT863180fb,serif;font-size:13.7pt">Treatment of malignant gliomas with ketogenic or caloric restricted</span></p>
<p style="top:194.5pt;left:32.8pt;line-height:13.7pt"><span style="font-family:AdvOT863180fb,serif;font-size:13.7pt">diets: A systematic review of preclinical and early clinical studies</span></p>
<p style="top:219.6pt;left:32.8pt;line-height:10.8pt"><span style="font-family:AdvOT863180fb,serif;font-size:10.8pt">Lotte Noorlag</span><span style="font-family:AdvOT863180fb,serif;font-size:7.8pt;color:#0a7fac"> </span><sup><span style="font-family:AdvOT863180fb,serif;font-size:7.8pt;color:#0a7fac">a</span></sup><span style="font-family:AdvOT863180fb,serif;font-size:10.8pt">, Filip Y. De Vos</span><span style="font-family:AdvOT863180fb,serif;font-size:7.8pt;color:#0a7fac"> </span><sup><span style="font-family:AdvOT863180fb,serif;font-size:7.8pt;color:#0a7fac">b</span></sup><span style="font-family:AdvOT863180fb,serif;font-size:10.8pt">, Annemieke Kok</span><span style="font-family:AdvOT863180fb,serif;font-size:7.8pt;color:#0a7fac"> </span><sup><span style="font-family:AdvOT863180fb,serif;font-size:7.8pt;color:#0a7fac">c</span></sup><span style="font-family:AdvOT863180fb,serif;font-size:10.8pt">, Marike L.D. Broekman</span><span style="font-family:AdvOT863180fb,serif;font-size:7.8pt;color:#0a7fac"> </span><sup><span style="font-family:AdvOT863180fb,serif;font-size:7.8pt;color:#0a7fac">d</span></sup><sup><span style="font-family:AdvOT863180fb,serif;font-size:7.6pt">,</span></sup><sup><span style="font-family:AdvOT863180fb,serif;font-size:7.8pt;color:#0a7fac"> e</span></sup><sup><span style="font-family:AdvOT863180fb,serif;font-size:7.6pt">,</span></sup><sup><span style="font-family:AdvOT863180fb,serif;font-size:7.8pt;color:#0a7fac"> f</span></sup><span style="font-family:AdvOT863180fb,serif;font-size:10.8pt">,</span></p>
<p style="top:232.6pt;left:32.8pt;line-height:10.8pt"><span style="font-family:AdvOT863180fb,serif;font-size:10.8pt">Tatjana Seute</span><span style="font-family:AdvOT863180fb,serif;font-size:7.8pt;color:#0a7fac"> </span><sup><span style="font-family:AdvOT863180fb,serif;font-size:7.8pt;color:#0a7fac">a</span></sup><span style="font-family:AdvOT863180fb,serif;font-size:10.8pt">, Pierre A. Robe</span><span style="font-family:AdvOT863180fb,serif;font-size:7.8pt;color:#0a7fac"> </span><sup><span style="font-family:AdvOT863180fb,serif;font-size:7.8pt;color:#0a7fac">d</span></sup><span style="font-family:AdvOT863180fb,serif;font-size:10.8pt">, Tom J. Snijders</span><span style="font-family:AdvOT863180fb,serif;font-size:7.8pt;color:#0a7fac"> </span><sup><span style="font-family:AdvOT863180fb,serif;font-size:7.8pt;color:#0a7fac">a</span></sup><sup><span style="font-family:AdvOT863180fb,serif;font-size:7.6pt">,</span></sup><sup><span style="font-family:AdvTT5843c571,serif;font-size:7.8pt;color:#0a7fac"> *</span></sup></p>
<p style="top:249.5pt;left:32.8pt;line-height:4.7pt"><span style="font-family:AdvOT863180fb,serif;font-size:4.7pt">a</span><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.5pt"> Brain Center Rudolf Magnus, Department of Neurology, University Medical Center Utrecht, G03.232, PO Box 85500, 3508 GA, Utrecht, the Netherlands</span></p>
<p style="top:258.1pt;left:32.8pt;line-height:4.7pt"><span style="font-family:AdvOT863180fb,serif;font-size:4.7pt">b</span><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.5pt"> Department of Medical Oncology, Internal Medicine and Dermatology, University Medical Center Utrecht, Utrecht, the Netherlands</span></p>
<p style="top:266.7pt;left:32.8pt;line-height:4.7pt"><span style="font-family:AdvOT863180fb,serif;font-size:4.7pt">c</span><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.5pt"> Department of Dietetics, University Medical Center Utrecht, Utrecht, the Netherlands</span></p>
<p style="top:275.3pt;left:32.8pt;line-height:4.7pt"><span style="font-family:AdvOT863180fb,serif;font-size:4.7pt">d</span><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.5pt"> Brain Center Rudolf Magnus, Department of Neurosurgery, University Medical Center Utrecht, Utrecht, the Netherlands</span></p>
<p style="top:283.8pt;left:32.8pt;line-height:4.7pt"><span style="font-family:AdvOT863180fb,serif;font-size:4.7pt">e</span><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.5pt"> Department of Neurosurgery, Leiden University Medical Center, Leiden, the Netherlands</span></p>
<p style="top:292.4pt;left:32.8pt;line-height:4.7pt"><span style="font-family:AdvOT863180fb,serif;font-size:4.7pt">f</span><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.5pt"> Department of Neurosurgery, Haaglanden Medical Center, The Hague, the Netherlands</span></p>
<p style="top:324.6pt;left:32.8pt;line-height:9.1pt"><span style="font-family:AdvOTc4d0b532,serif;font-size:9.1pt">a r t i c l e</span></p>
<p style="top:324.6pt;left:96.8pt;line-height:9.1pt"><span style="font-family:AdvOTc4d0b532,serif;font-size:9.1pt">i n f o</span></p>
<p style="top:345.2pt;left:32.8pt;line-height:6.5pt"><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.5pt">Article history:</span></p>
<p style="top:353.8pt;left:32.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Received 22 February 2018</span></p>
<p style="top:362.3pt;left:32.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Accepted 30 October 2018</span></p>
<p style="top:382.1pt;left:32.8pt;line-height:6.5pt"><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.5pt">Keywords:</span></p>
<p style="top:390.7pt;left:32.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Glioma</span></p>
<p style="top:399.3pt;left:32.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Glioblastoma</span></p>
<p style="top:407.9pt;left:32.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Ketogenic diet</span></p>
<p style="top:416.4pt;left:32.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Caloric restriction</span></p>
<p style="top:425.0pt;left:32.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Short-term starvation</span></p>
<p style="top:433.5pt;left:32.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Targeted therapy</span></p>
<p style="top:324.6pt;left:197.2pt;line-height:9.1pt"><span style="font-family:AdvOTc4d0b532,serif;font-size:9.1pt">s u m m a r y</span></p>
<p style="top:345.5pt;left:197.2pt;line-height:7.3pt"><span style="font-family:AdvOTb92eb7df.I,serif;font-size:7.3pt">Background</span><span style="font-family:AdvTTf90d833a.I,serif;font-size:7.3pt"> &amp;</span><span style="font-family:AdvOTb92eb7df.I,serif;font-size:7.3pt"> aims:</span><span style="font-family:AdvOT863180fb,serif;font-size:7.3pt"> Patients with malignant gliomas have a poor prognosis. Diets that lower blood</span></p>
<p style="top:355.1pt;left:197.2pt;line-height:7.3pt"><span style="font-family:AdvOT863180fb,serif;font-size:7.3pt">glucose, such as ketogenic or caloric restricted diets (KCRDs), are hypothesized to reduce tumor growth</span></p>
<p style="top:364.6pt;left:197.2pt;line-height:7.3pt"><span style="font-family:AdvOT863180fb,serif;font-size:7.3pt">and improve survival. In this systematic review, we summarize preclinical and clinical data on KCRDs in</span></p>
<p style="top:374.2pt;left:197.2pt;line-height:7.3pt"><span style="font-family:AdvOT863180fb,serif;font-size:7.3pt">gliomas.</span></p>
<p style="top:383.8pt;left:197.2pt;line-height:7.3pt"><span style="font-family:AdvOTb92eb7df.I,serif;font-size:7.3pt">Methods:</span><span style="font-family:AdvOT863180fb,serif;font-size:7.3pt"> We searched PubMed and Embase for preclinical and clinical studies on KCRDs in gliomas, and</span></p>
<p style="top:393.4pt;left:197.2pt;line-height:7.3pt"><span style="font-family:AdvOT863180fb,serif;font-size:7.3pt">extracted data on surrogate and clinically relevant endpoints, in accordance with PRISMA statement.</span></p>
<p style="top:402.9pt;left:197.2pt;line-height:7.3pt"><span style="font-family:AdvOT863180fb,serif;font-size:7.3pt">Quality assessment of clinical studies was performed with use of Cochrane Collaboration&apos;s tool. We</span></p>
<p style="top:412.5pt;left:197.2pt;line-height:7.3pt"><span style="font-family:AdvOT863180fb,serif;font-size:7.3pt">performed Fisher&apos;s exact test to examine associations between surrogate and clinically relevant</span></p>
<p style="top:422.1pt;left:197.2pt;line-height:7.3pt"><span style="font-family:AdvOT863180fb,serif;font-size:7.3pt">endpoints.</span></p>
<p style="top:431.6pt;left:197.2pt;line-height:7.3pt"><span style="font-family:AdvOTb92eb7df.I,serif;font-size:7.3pt">Results:</span><span style="font-family:AdvOT863180fb,serif;font-size:7.3pt"> We included 24 preclinical studies, seven clinical studies and one mixed study. Both preclinical</span></p>
<p style="top:441.2pt;left:197.2pt;line-height:7.3pt"><span style="font-family:AdvOT863180fb,serif;font-size:7.3pt">and clinical studies were highly heterogeneous. Preclinically, KCRDs reduced tumor growth, but only a</span></p>
<p style="top:450.8pt;left:197.2pt;line-height:7.3pt"><span style="font-family:AdvOT863180fb,serif;font-size:7.3pt">small majority of the</span><span style="font-family:AdvOTb92eb7df.I,serif;font-size:7.3pt"> in vivo</span><span style="font-family:AdvOT863180fb,serif;font-size:7.3pt"> studies found improved survival. These effects were stronger in groups with</span></p>
<p style="top:460.3pt;left:197.2pt;line-height:7.3pt"><span style="font-family:AdvOT863180fb,serif;font-size:7.3pt">decreased blood glucose than in those with increased ketones, and also when other therapies were used</span></p>
<p style="top:469.9pt;left:197.2pt;line-height:7.3pt"><span style="font-family:AdvOT863180fb,serif;font-size:7.3pt">concomitantly. Finally, KCRDs in</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:7.3pt">&#xfb02;</span><span style="font-family:AdvOT863180fb,serif;font-size:7.3pt">uence multiple molecular-biological pathways, including the PTEN/Akt/</span></p>
<p style="top:479.4pt;left:197.2pt;line-height:7.3pt"><span style="font-family:AdvOT863180fb,serif;font-size:7.3pt">TSC2 and NF-kB pathway. In clinical studies, KCRDs seem to be safe and feasible in glioma patients.</span></p>
<p style="top:489.0pt;left:197.2pt;line-height:7.3pt"><span style="font-family:AdvOT863180fb,serif;font-size:7.3pt">Clinical data were insuf</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:7.3pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:7.3pt">cient to draw conclusions regarding ef</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:7.3pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:7.3pt">cacy.</span></p>
<p style="top:498.5pt;left:197.2pt;line-height:7.3pt"><span style="font-family:AdvOTb92eb7df.I,serif;font-size:7.3pt">Conclusions:</span><span style="font-family:AdvOT863180fb,serif;font-size:7.3pt"> KCRDs have positive effects on malignant gliomas in published preclinical studies. Pre-</span></p>
<p style="top:508.1pt;left:197.2pt;line-height:7.3pt"><span style="font-family:AdvOT863180fb,serif;font-size:7.3pt">liminary clinical data suggest that KCRDs are safe and feasible. However, because of the paucity of clinical</span></p>
<p style="top:517.7pt;left:197.2pt;line-height:7.3pt"><span style="font-family:AdvOT863180fb,serif;font-size:7.3pt">data, the ef</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:7.3pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:7.3pt">cacy of KCRDs for improving survival and quality of life of glioma patients remains to be</span></p>
<p style="top:527.2pt;left:197.2pt;line-height:7.3pt"><span style="font-family:AdvOT863180fb,serif;font-size:7.3pt">proven in prospective studies.</span></p>
<p style="top:536.8pt;left:207.8pt;line-height:7.3pt"><span style="font-family:AdvOTb0c9bf5d,serif;font-size:7.3pt">&#xa9;</span><span style="font-family:AdvOT863180fb,serif;font-size:7.3pt"> 2018 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.</span></p>
<p style="top:595.1pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOTb83ee1dd.B,serif;font-size:8.1pt">1. Introduction</span></p>
<p style="top:616.0pt;left:313.7pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">Malignant gliomas are primary brain tumors and comprise</span></p>
<p style="top:626.5pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">anaplastic gliomas (WHO grade III) and glioblastomas (grade IV)</span></p>
<p style="top:637.0pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac">[1]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">. The standard treatment for glioblastomas, the most common</span></p>
<p style="top:647.4pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">and lethal subtype</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [2]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">, is maximal surgical resection, followed by</span></p>
<p style="top:657.9pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">radiotherapy</span></p>
<p style="top:657.9pt;left:357.4pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">with</span></p>
<p style="top:657.9pt;left:382.2pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">concomitant</span></p>
<p style="top:657.9pt;left:436.7pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">and</span></p>
<p style="top:657.9pt;left:458.1pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">adjuvant</span></p>
<p style="top:657.9pt;left:498.4pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">temozolomide</span></p>
<p style="top:668.4pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">chemotherapy</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [3,4]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">. Despite this aggressive policy, practically all</span></p>
<p style="top:678.8pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">patients develop disease progression or recurrence with limited</span></p>
<p style="top:689.3pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">second-line treatment options</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [3]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">, resulting in a poor 5-year overall</span></p>
<p style="top:615.5pt;left:44.8pt;line-height:6.5pt"><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.5pt">Abbreviations:</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt"> AMPK, AMP-activated protein kinase; BTIC, brain tumor initi-</span></p>
<p style="top:624.1pt;left:32.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">ating cell; CR, caloric restriction (or caloric restricted conditions</span><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.5pt"> in vitro</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">); HIF-1</span><span style="font-family:AdvP3F4C13,serif;font-size:7.0pt">a</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">,</span></p>
<p style="top:632.7pt;left:32.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">hypoxia inducible factor-1</span><span style="font-family:AdvP3F4C13,serif;font-size:7.0pt">a</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">; IGF-I, insulin-like growth factor I; IGF-IR, insulin-like</span></p>
<p style="top:641.2pt;left:32.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">growth factor I receptor; KCRD, ketogenic or caloric restricted diet; KD, ketogenic</span></p>
<p style="top:649.8pt;left:32.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">diet; KD-R, restricted ketogenic diet; KD-UR, unrestricted ketogenic diet; KS, ketone</span></p>
<p style="top:658.3pt;left:32.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">supplementation; mTOR, mechanistic target of rapamycin; PFS, progression-free</span></p>
<p style="top:666.9pt;left:32.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">survival; PTEN, phosphatase and tensin homologue; STS, short-term starvation (or</span></p>
<p style="top:675.5pt;left:32.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">STS-mimicking conditions</span><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.5pt"> in vitro</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">); TIN, treatment-induced necrosis; TSC2, tuber-</span></p>
<p style="top:684.1pt;left:32.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">ous sclerosis complex 2; VEGF, vascular endothelial growth factor; VEGFR2, VEGF-</span></p>
<p style="top:692.6pt;left:32.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">receptor-2.</span></p>
<p style="top:701.2pt;left:37.9pt;line-height:6.5pt"><span style="font-family:AdvTT5843c571,serif;font-size:6.5pt">*</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt"> Corresponding author. Fax:</span><span style="font-family:AdvP4C4E74,serif;font-size:6.5pt"> &#xfe;</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">31 (0)30 2542100.</span></p>
<p style="top:709.8pt;left:44.8pt;line-height:6.5pt"><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.5pt">E-mail address:</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> T.J.Snijders@umcutrecht.nl</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt"> (T.J. Snijders).</span></p>
<img style="position:absolute;transform:matrix(.32003335,0,-0,.31878994,620.754,197.62796)" src="data:image/png;base64,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=">
<img style="position:absolute;transform:matrix(.31973756,0,-0,.31894965,-43.685335,1.7126312)" src="data:image/jpeg;base64,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==">
<p style="top:73.3pt;left:216.5pt;line-height:8.1pt"><span style="font-family:AdvPSA35D,serif;font-size:8.1pt">Contents lists available at</span><span style="font-family:AdvPSA35D,serif;font-size:8.1pt;color:#0a7fac"> ScienceDirect</span></p>
<p style="top:97.4pt;left:237.3pt;line-height:14.2pt"><span style="font-family:AdvOT863180fb,serif;font-size:14.2pt">Clinical Nutrition</span></p>
<p style="top:129.2pt;left:162.5pt;line-height:8.1pt"><span style="font-family:AdvPSA35D,serif;font-size:8.1pt">journal homepage:</span><span style="font-family:AdvPSA35D,serif;font-size:8.1pt;color:#0a7fac"> http://www.elsevier.com/locate/clnu</span></p>
<img style="position:absolute;transform:matrix(.31975813,0,-0,.31895948,581.68606,-11.294037)" src="data:image/jpeg;base64,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">
<p style="top:728.1pt;left:32.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">https://doi.org/10.1016/j.clnu.2018.10.024</span></p>
<p style="top:736.7pt;left:32.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">0261-5614/</span><span style="font-family:AdvOTb0c9bf5d,serif;font-size:6.5pt">&#xa9;</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt"> 2018 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.</span></p>
<p style="top:47.8pt;left:235.0pt;line-height:6.4pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.4pt;color:#0a7fac">Clinical Nutrition 38 (2019) 1986</span><span style="font-family:AdvPS44A44B,serif;font-size:6.4pt;color:#0a7fac">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.4pt;color:#0a7fac">1994</span></p>


<p style="top:66.1pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">survival of 5</span><span style="font-family:AdvPS44A44B,serif;font-size:8.1pt">e</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">10%</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [2,5,6]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">. The prognosis for anaplastic gliomas is</span></p>
<p style="top:76.6pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">better, but these tumors are still invariably fatal.</span></p>
<p style="top:87.0pt;left:54.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">Insights in glucose metabolism may offer new treatment op-</span></p>
<p style="top:97.5pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">tions. In non-tumor cells, ATP is mainly produced by the citric acid</span></p>
<p style="top:108.0pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">cycle and oxidative phosphorylation in mitochondria. A common</span></p>
<p style="top:118.4pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">characteristic of tumor cells</span><span style="font-family:AdvPS44A44B,serif;font-size:8.1pt"> e</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> including glioblastoma cells</span><span style="font-family:AdvPS44A44B,serif;font-size:8.1pt"> e</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> is,</span></p>
<p style="top:128.9pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">however, their supposed dependence on glycolysis for the pro-</span></p>
<p style="top:139.3pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">duction of ATP, regardless of the presence of oxygen (the</span><span style="font-family:AdvOT863180fb+20,serif;font-size:8.1pt"> &#x2018;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">Warburg</span></p>
<p style="top:149.8pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">effect</span><span style="font-family:AdvOT863180fb+20,serif;font-size:8.1pt">&#x2019;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">)</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [7]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">. This led to the hypothesis that tumor cells have</span></p>
<p style="top:160.2pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">dysfunctional</span></p>
<p style="top:160.2pt;left:100.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">mitochondria,</span></p>
<p style="top:160.2pt;left:160.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">and</span></p>
<p style="top:160.2pt;left:182.1pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">since</span></p>
<p style="top:160.2pt;left:208.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">these</span></p>
<p style="top:160.2pt;left:235.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">organelles</span></p>
<p style="top:160.2pt;left:281.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">are</span></p>
<p style="top:170.7pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">involved in apoptosis, their dysfunction could lead to tumor cells&apos;</span></p>
<p style="top:181.1pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">survival</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [8,9]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">. Moreover, tumor cells seem to be less able to use</span></p>
<p style="top:191.6pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ketone bodies as their primary energy source in glucose restricted</span></p>
<p style="top:202.1pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">conditions</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [8]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">. This hypothesis is supported by the</span><span style="font-family:AdvOTb92eb7df.I,serif;font-size:8.1pt"> in vitro</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> obser-</span></p>
<p style="top:212.6pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">vation of reduced expression of ketolytic enzymes in gliomas</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [10]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">.</span></p>
<p style="top:223.0pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">Another contributing factor to the Warburg effect is altered cell</span></p>
<p style="top:233.5pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">signaling, which is re</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb02;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ected in gliomas, for example, mutations in</span></p>
<p style="top:243.9pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">the mechanistic target of rapamycin (mTOR) pathway</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [11]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">.</span></p>
<p style="top:254.4pt;left:54.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">These insights, the</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt"> &#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">nding that hyperglycemia is associated with</span></p>
<p style="top:264.8pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">a worse prognosis</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [12]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">, and the</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt"> &#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">nding that ketones may have</span></p>
<p style="top:275.3pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">direct antitumor effects through the inhibition of histone deace-</span></p>
<p style="top:285.8pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">tylation (HDAC)</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [13]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> led to the development of dietary in-</span></p>
<p style="top:296.2pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">terventions to reduce blood glucose and thus induce ketosis, such</span></p>
<p style="top:306.7pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">as a ketogenic diet (KD), caloric restriction (CR) and short-term</span></p>
<p style="top:317.2pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">starvation (STS). A KD is a diet with a fat to carbohydrate and</span></p>
<p style="top:327.6pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">protein ratio of 4:1 (a standard diet has a ratio of less than 1), and</span></p>
<p style="top:338.1pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">can be used with and without CR. Both the unrestricted and</span></p>
<p style="top:348.6pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">restricted KD, CR and STS result in lower blood glucose and higher</span></p>
<p style="top:359.0pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">blood ketones</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [14,15]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">, and are here collectively termed</span><span style="font-family:AdvOT863180fb+20,serif;font-size:8.1pt"> &#x2018;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ketogenic</span></p>
<p style="top:369.5pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">or caloric restricted diets</span><span style="font-family:AdvOT863180fb+20,serif;font-size:8.1pt">&#x2019;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> (KCRDs). The effects of KCRDs can be</span></p>
<p style="top:379.9pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">simulated preclinically by ketone supplementation (KS).</span></p>
<p style="top:390.4pt;left:54.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">The aim of this review is to summarize all preclinical and early</span></p>
<p style="top:400.8pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">clinical data on KCRDs for the treatment of malignant gliomas. We</span></p>
<p style="top:411.3pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">address the following research questions:</span></p>
<p style="top:432.2pt;left:44.9pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">1. What are the effects of KCRDs on malignant gliomas</span><span style="font-family:AdvOTb92eb7df.I,serif;font-size:8.1pt"> in vitro</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> and</span></p>
<p style="top:442.7pt;left:54.4pt;line-height:8.1pt"><span style="font-family:AdvOTb92eb7df.I,serif;font-size:8.1pt">in vivo</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">, with regard to endpoints including blood glucose and</span></p>
<p style="top:453.2pt;left:54.4pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ketone concentrations, tumor growth, cell death, and survival?</span></p>
<p style="top:463.6pt;left:44.2pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">2. Which molecular-biological pathways and mechanisms are</span></p>
<p style="top:474.1pt;left:54.4pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">in</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb02;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">uenced by KCRDs that may contribute to the effects of</span></p>
<p style="top:484.5pt;left:54.4pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">KCRDs?</span></p>
<p style="top:495.0pt;left:44.2pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">3. What are the effects of KCRDs as (adjunct) treatment modalities</span></p>
<p style="top:505.4pt;left:54.4pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">in glioma patients, with regard to endpoints including blood</span></p>
<p style="top:515.9pt;left:54.4pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">glucose and ketone concentrations, tumor growth, survival,</span></p>
<p style="top:526.3pt;left:54.4pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">safety, feasibility, and quality of life?</span></p>
<p style="top:557.8pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOTb83ee1dd.B,serif;font-size:8.1pt">2. Methods</span></p>
<p style="top:578.7pt;left:54.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">We conducted a systematic search in PubMed and Embase (July</span></p>
<p style="top:589.1pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">1, 2017) that combined synonyms for gliomas and KCRDs (see</span></p>
<p style="top:599.6pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac">Supplemental Tables 1 and 2</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">).</span></p>
<p style="top:610.0pt;left:54.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">This paper is performed in accordance with the PRISMA</span></p>
<p style="top:620.5pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">(Preferred Reporting Items for Systematic Reviews and Meta-</span></p>
<p style="top:631.0pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">Analyses) statement</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [16]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">, which is primarily intended for system-</span></p>
<p style="top:641.4pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">atic reviews and meta-analyses of clinical intervention studies. This</span></p>
<p style="top:651.9pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">paper mainly focuses on preclinical studies, but we adhered to the</span></p>
<p style="top:662.4pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">guidelines as closely as possible. The review protocol was reviewed</span></p>
<p style="top:672.8pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">internally (among the authors) before completion of the search and</span></p>
<p style="top:683.3pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">data extraction. No formal review protocol was submitted to the</span></p>
<p style="top:693.8pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">public domain.</span></p>
<p style="top:704.2pt;left:54.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">After removing duplicate records, a step-by-step selection pro-</span></p>
<p style="top:714.7pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">cess based on titles, abstracts and full texts was performed (LN and</span></p>
<p style="top:725.1pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">FYV). We checked the completeness of the search by a</span><span style="font-family:AdvOT863180fb+20,serif;font-size:8.1pt"> &#x2018;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">golden hit</span><span style="font-family:AdvOT863180fb+20,serif;font-size:8.1pt">&#x2019;</span></p>
<p style="top:735.6pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">list. This list of landmark papers on KCRDs was made prior to and</span></p>
<p style="top:66.1pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">independent of the search (AK). We hand-searched reference lists</span></p>
<p style="top:76.5pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">of</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt"> &#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ve relevant reviews</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [17</span><span style="font-family:AdvPS44A44B,serif;font-size:8.1pt;color:#0a7fac">e</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac">21]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">, and contacted authors of papers</span></p>
<p style="top:87.0pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">that were not available through our institution to identify addi-</span></p>
<p style="top:97.5pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">tional papers. LN performed and TJS reviewed the data extraction.</span></p>
<p style="top:108.0pt;left:323.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">For all studies, we applied the following inclusion criteria: 1)</span></p>
<p style="top:118.4pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">articles had to be written in English; 2) articles concerned original</span></p>
<p style="top:128.9pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">research (including observational clinical studies, case reports and</span></p>
<p style="top:139.3pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">clinical</span></p>
<p style="top:139.3pt;left:345.7pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">abstracts).</span></p>
<p style="top:139.3pt;left:391.7pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">Reviews,</span></p>
<p style="top:139.3pt;left:432.1pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">editorials</span></p>
<p style="top:139.3pt;left:474.9pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">and</span></p>
<p style="top:139.3pt;left:496.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">comments</span></p>
<p style="top:139.3pt;left:543.7pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">were</span></p>
<p style="top:149.8pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">excluded.</span></p>
<p style="top:160.2pt;left:323.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">Additional inclusion criteria for preclinical studies were: 1) the</span></p>
<p style="top:170.7pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">domain had to be a glioma cell line or model; 2) the study included</span></p>
<p style="top:181.1pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">a KCRD intervention; 3) data on one of the endpoints of interest</span></p>
<p style="top:191.6pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">were reported.</span></p>
<p style="top:202.1pt;left:323.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">Additional inclusion criteria for clinical studies were: 1) patients</span></p>
<p style="top:212.6pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">(either adults or children) were diagnosed with a malignant glioma</span></p>
<p style="top:223.0pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">(WHO grade III or IV)</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [1]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">; 2) patients were treated with a KCRD</span></p>
<p style="top:233.5pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">(before, during or after standard treatments).</span></p>
<p style="top:243.9pt;left:323.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">Results are mainly presented in a descriptive manner. We</span></p>
<p style="top:254.4pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">categorized results based on the study design (</span><span style="font-family:AdvOTb92eb7df.I,serif;font-size:8.1pt">in vitro</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">,</span><span style="font-family:AdvOTb92eb7df.I,serif;font-size:8.1pt"> in vivo</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> or</span></p>
<p style="top:264.8pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">clinical);</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> Supplemental Tables 3 and 4</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> contain study characteristics</span></p>
<p style="top:275.3pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">of the preclinical and clinical studies, respectively. We also sub-</span></p>
<p style="top:285.8pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">divided outcome measures in surrogate (laboratory) and clinically</span></p>
<p style="top:296.2pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">relevant endpoints. Surrogate endpoints include blood glucose and</span></p>
<p style="top:306.7pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ketone concentration, since these are used to monitor the effects of</span></p>
<p style="top:317.2pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">KCRDs in the clinical practice (reference values in the treatment of</span></p>
<p style="top:327.6pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">refractory epilepsy with a KD are 2</span><span style="font-family:AdvPS44A44B,serif;font-size:8.1pt">e</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">5 mmol/L for blood ketones</span></p>
<p style="top:338.1pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">and 8</span><span style="font-family:AdvPS44A44B,serif;font-size:8.1pt">e</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">16 mmol/L for urine ketones</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [22]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">), and antiangiogenic ef-</span></p>
<p style="top:348.6pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">fects, since tumor growth is partly dependent on angiogenesis</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [23]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">.</span></p>
<p style="top:359.0pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">Clinically relevant endpoints include tumor growth, survival, and</span></p>
<p style="top:369.5pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">quality of life (the latter in clinical studies). Other (secondary)</span></p>
<p style="top:379.9pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">endpoints are described in the Results section or presented in</span></p>
<p style="top:390.4pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac">Supplemental Table 5</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">.</span></p>
<p style="top:400.8pt;left:323.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">Quality assessment of clinical studies was performed with use of</span></p>
<p style="top:411.3pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">the Cochrane Collaboration&apos;s tool for assessing risk of bias</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [24]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">. We</span></p>
<p style="top:421.7pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">considered laboratory effects, tumor growth and survival as</span></p>
<p style="top:432.2pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">essential parameters, and they should have been reported in all</span></p>
<p style="top:442.7pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">clinical studies. Therefore, if one of the essential parameters was</span></p>
<p style="top:453.2pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">not reported, incomplete outcome data for that essential parame-</span></p>
<p style="top:463.6pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ters was scored as unclear risk of bias. Safety and feasibility and</span></p>
<p style="top:474.1pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">quality of life were considered as non-essential parameters, and if</span></p>
<p style="top:484.5pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">one of these was not reported, this was scored as not applicable. We</span></p>
<p style="top:495.0pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">performed a Fisher&apos;s exact test (VassarStats) to examine whether</span></p>
<p style="top:505.4pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">laboratory effects of KCRDs are associated with clinically relevant</span></p>
<p style="top:515.9pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">effects in the preclinical studies. We used this simpli</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ed method,</span></p>
<p style="top:526.3pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">since a formal meta-regression was not possible due to the het-</span></p>
<p style="top:536.8pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">erogeneity of the preclinical studies.</span></p>
<p style="top:563.0pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOTb83ee1dd.B,serif;font-size:8.1pt">3. Results</span></p>
<p style="top:583.9pt;left:323.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">After the step-by-step selection process, 29 records remained.</span></p>
<p style="top:594.4pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">The hand-searching of reference lists and contacting of authors</span></p>
<p style="top:604.8pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">resulted in three additional records</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [25</span><span style="font-family:AdvPS44A44B,serif;font-size:8.1pt;color:#0a7fac">e</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac">27]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">. Adding these resulted</span></p>
<p style="top:615.3pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">in a</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt"> &#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">nal selection of 32 records (</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac">Fig. 1</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">), consisting of 24 preclinical</span></p>
<p style="top:625.7pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">studies, seven clinical studies and one study that contained both</span></p>
<p style="top:636.2pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">clinical and preclinical data.</span></p>
<p style="top:662.4pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOTb92eb7df.I,serif;font-size:8.1pt">3.1. In vitro preclinical studies</span></p>
<p style="top:683.3pt;left:323.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">Ten studies implemented KCRDs</span><span style="font-family:AdvOTb92eb7df.I,serif;font-size:8.1pt"> in vitro</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [26,28</span><span style="font-family:AdvPS44A44B,serif;font-size:8.1pt;color:#0a7fac">e</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac">36]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">; seven re-</span></p>
<p style="top:693.8pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ported on endpoints as listed in</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> Table 1 [26,29</span><span style="font-family:AdvPS44A44B,serif;font-size:8.1pt;color:#0a7fac">e</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac">33,36]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">, and three</span></p>
<p style="top:704.2pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">reported on molecular-biological pathways</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [28,34,35]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">. One study</span></p>
<p style="top:714.7pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">supplied ketones to glioma cell lines</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [30]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">, four studies lowered</span></p>
<p style="top:725.1pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">glucose concentrations in media to mimic CR or STS</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [29,31</span><span style="font-family:AdvPS44A44B,serif;font-size:8.1pt;color:#0a7fac">e</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac">33]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">,</span></p>
<p style="top:735.6pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">and two studies used both</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [26,36]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">.</span></p>
<p style="top:47.8pt;left:221.2pt;line-height:6.4pt"><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.4pt">L. Noorlag et al. / Clinical Nutrition 38 (2019) 1986</span><span style="font-family:AdvPS44A44B,serif;font-size:6.4pt">e</span><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.4pt">1994</span></p>
<p style="top:47.8pt;left:548.3pt;line-height:6.4pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.4pt">1987</span></p>


<p style="top:599.2pt;left:44.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">Maurer et al. found no differences in tumor growth, motility and</span></p>
<p style="top:609.7pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">invasiveness after KS, compared with a standard diet</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [30]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">. Inter-</span></p>
<p style="top:620.1pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">estingly, the authors observed that ketone bodies rescued hippo-</span></p>
<p style="top:630.6pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">campal neurons from cell death induced by glucose withdrawal, but</span></p>
<p style="top:641.1pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">did not sensitize tumor cells to temozolomide.</span></p>
<p style="top:651.5pt;left:44.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">In one study, the death rate of tumor cells increased syner-</span></p>
<p style="top:662.0pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">gistically when doxorubicin was added to low glucose concen-</span></p>
<p style="top:672.5pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">trations</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [29]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">.</span></p>
<p style="top:693.8pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOTb92eb7df.I,serif;font-size:8.1pt">3.2. In vivo preclinical studies</span></p>
<p style="top:714.7pt;left:44.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">Twenty-four studies had an</span><span style="font-family:AdvOTb92eb7df.I,serif;font-size:8.1pt"> in vivo</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> study design, and were</span></p>
<p style="top:725.1pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">highly heterogeneous with regard to the KCRDs used and the</span></p>
<p style="top:735.6pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">endpoints reported. Therefore, these studies are categorized based</span></p>
<p style="top:66.1pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">on the KCRD used, as presented in</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> Table 2</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> (clinically relevant</span></p>
<p style="top:76.5pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">endpoints) and</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> Table 3</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> (surrogate endpoints). All studies compared</span></p>
<p style="top:87.0pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">results in animals on a KCDR with those on a standard diet.</span></p>
<p style="top:116.9pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOTb92eb7df.I,serif;font-size:8.1pt">3.2.1. Ketogenic diet</span></p>
<p style="top:127.3pt;left:313.7pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">Twelve studies implemented a KD</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [25,30,34</span><span style="font-family:AdvPS44A44B,serif;font-size:8.1pt;color:#0a7fac">e</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac">43]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">, with keto-</span></p>
<p style="top:137.8pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">genic ratios (grams of fat to grams of carbohydrate and protein)</span></p>
<p style="top:148.3pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">varying from 2.7:1</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [30]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> to 6:1</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [34,36]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">. Eight studies used a caloric</span></p>
<p style="top:158.8pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">unrestricted KD (KD-UR)</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [25,30,34,36,37,39,41,43]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">, and two a</span></p>
<p style="top:169.2pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">caloric restricted KD (KD-R)</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [35,38]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">. One was designed to reduce</span></p>
<p style="top:179.7pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">body weight by 20% in ten days</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [38]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">, while the other eased CR when</span></p>
<p style="top:190.2pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">body weight was reduced by 20% or more</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [35]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">. Two studies</span></p>
<p style="top:200.6pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">implemented a KD-UR in one group and a KD-R in another, wherein</span></p>
<p style="top:211.1pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">the caloric intake was restricted by 35</span><span style="font-family:AdvPS44A44B,serif;font-size:8.1pt">e</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">40% compared with the</span></p>
<p style="top:221.5pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">recommended daily allowance</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [40,42]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">.</span></p>
<p style="top:232.0pt;left:313.7pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">Zhou et al. used a subcutaneous and intracerebral glioma model</span></p>
<p style="top:242.4pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac">[42]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">. They used tumor growth to 2.5 cm</span><sup><span style="font-family:AdvOT863180fb,serif;font-size:6.1pt">3</span></sup><sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> </span></sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">as a proxy for survival in</span></p>
<p style="top:252.9pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">the subcutaneous model, and tumor growth differences in the</span></p>
<p style="top:263.4pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">intracerebral</span></p>
<p style="top:263.4pt;left:357.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">model.</span></p>
<p style="top:263.4pt;left:391.1pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">Survival</span></p>
<p style="top:263.4pt;left:429.0pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">increased</span></p>
<p style="top:263.4pt;left:472.6pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">and</span></p>
<p style="top:263.4pt;left:494.3pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">tumor</span></p>
<p style="top:263.4pt;left:525.4pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">growth</span></p>
<p style="top:273.8pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">decreased with the KD-R, but not with the KD-UR. Seyfried et al.</span></p>
<p style="top:284.3pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">found the same with an intracerebral model: tumor growth was</span></p>
<p style="top:294.8pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">only reduced with the KD-R</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [40]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">.</span></p>
<p style="top:305.2pt;left:313.7pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">Poff et al. used a subcutaneous model and reported no decrease</span></p>
<p style="top:315.7pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">in tumor growth in the KD-UR group, but nevertheless found</span></p>
<p style="top:326.1pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">improved survival compared with the control group</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [25]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">.</span></p>
<p style="top:336.6pt;left:313.7pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">Four studies added the KD to another treatment modality. When</span></p>
<p style="top:347.0pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">the KD was used concomitantly with radiotherapy, hyperbaric ox-</span></p>
<p style="top:357.5pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ygen therapy, 2-deoxy-</span><span style="font-family:AdvOT863180fb,serif;font-size:5.7pt">D</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">-glucose, or bevacizumab, synergistic ef-</span></p>
<p style="top:368.0pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">fects with regard to reduced tumor growth and improved survival</span></p>
<p style="top:378.4pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">were found</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [25,37</span><span style="font-family:AdvPS44A44B,serif;font-size:8.1pt;color:#0a7fac">e</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac">39]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">.</span></p>
<p style="top:388.9pt;left:313.7pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">Blood glucose concentrations decreased signi</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">cantly with the</span></p>
<p style="top:399.4pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">KD-R, but not with the KD-UR in two studies</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [40,42]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">. Blood ketone</span></p>
<p style="top:409.8pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">concentrations, however, increased with both interventions. Zhou</span></p>
<p style="top:420.3pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">et al. found no antiangiogenic effects of the KD-UR, but the KD-R</span></p>
<p style="top:430.7pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">reduced tumor microvessel density</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [42]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">. The KD-UR in the study</span></p>
<p style="top:441.2pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">of Woolf et al. did not reduce the VEGF concentration, but the ex-</span></p>
<p style="top:451.6pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">pressions of VEGFR2, CD31 and the VEGF-B gene were reduced,</span></p>
<p style="top:462.1pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">which seems to indicate reduced angiogenesis</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [41]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">. In addition, the</span></p>
<img style="position:absolute;transform:matrix(.31992705,0,-0,.31993128,-290.818,-273.346)" src="data:image/jpeg;base64,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=">
<p style="top:332.8pt;left:78.0pt;line-height:6.4pt"><span style="font-family:AdvOTb83ee1dd.B,serif;font-size:6.4pt">Fig. 1.</span><span style="font-family:AdvOT863180fb,serif;font-size:6.4pt"> Flowchart of the step-by-step selection process.</span></p>
<p style="top:360.2pt;left:32.8pt;line-height:6.5pt"><span style="font-family:AdvOTb83ee1dd.B,serif;font-size:6.5pt">Table 1</span></p>
<p style="top:368.7pt;left:32.8pt;line-height:6.5pt"><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.5pt">In vitro</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt"> studies: summary of results for clinically relevant endpoints.</span><sup><span style="font-family:AdvOT863180fb,serif;font-size:4.7pt;color:#0a7fac">a</span></sup></p>
<p style="top:382.9pt;left:148.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Signi</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:6.5pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">cant?</span></p>
<p style="top:382.9pt;left:198.0pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">KS</span></p>
<p style="top:382.9pt;left:219.7pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">CR or STS</span></p>
<p style="top:382.9pt;left:262.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Total</span></p>
<p style="top:396.0pt;left:38.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Decreased tumor growth</span></p>
<p style="top:396.0pt;left:148.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Yes</span></p>
<p style="top:396.0pt;left:198.0pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">2</span></p>
<p style="top:396.0pt;left:219.7pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">3</span></p>
<p style="top:396.0pt;left:262.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">5</span></p>
<p style="top:404.6pt;left:148.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">No</span></p>
<p style="top:404.6pt;left:198.0pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">1</span></p>
<p style="top:404.6pt;left:262.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">1</span></p>
<p style="top:413.2pt;left:38.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Increased stress resistance of</span></p>
<p style="top:421.8pt;left:46.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">normal brain cells</span></p>
<p style="top:413.2pt;left:148.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Yes</span></p>
<p style="top:413.2pt;left:198.0pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">1</span></p>
<p style="top:413.2pt;left:262.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">1</span></p>
<p style="top:430.3pt;left:38.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Increased chemotoxicity</span></p>
<p style="top:438.9pt;left:46.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">resistance of normal brain</span></p>
<p style="top:447.4pt;left:46.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">cells</span></p>
<p style="top:430.3pt;left:148.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Yes</span></p>
<p style="top:430.3pt;left:219.7pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">1</span></p>
<p style="top:430.3pt;left:262.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">1</span></p>
<p style="top:456.0pt;left:38.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Sensitization of tumor cells to</span></p>
<p style="top:464.6pt;left:46.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">chemotherapy</span></p>
<p style="top:456.0pt;left:148.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Yes</span></p>
<p style="top:456.0pt;left:219.7pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">3</span></p>
<p style="top:456.0pt;left:262.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">3</span></p>
<p style="top:464.6pt;left:148.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">No</span></p>
<p style="top:464.6pt;left:198.0pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">1</span></p>
<p style="top:464.6pt;left:262.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">1</span></p>
<p style="top:473.2pt;left:38.8pt;line-height:6.5pt"><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.5pt">Increased death rates of tumor cells</span></p>
<p style="top:481.7pt;left:45.2pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">KCRD intervention only</span></p>
<p style="top:481.7pt;left:148.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Yes</span></p>
<p style="top:481.7pt;left:198.0pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">1</span></p>
<p style="top:481.7pt;left:219.7pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">3</span></p>
<p style="top:481.7pt;left:262.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">4</span></p>
<p style="top:490.3pt;left:45.2pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Combined with</span></p>
<p style="top:498.9pt;left:51.6pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">chemotherapy</span></p>
<p style="top:490.3pt;left:148.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Yes</span></p>
<p style="top:490.3pt;left:219.7pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">1</span></p>
<p style="top:490.3pt;left:262.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">1</span></p>
<p style="top:512.0pt;left:32.8pt;line-height:6.5pt"><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.5pt">Abbreviations</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">: CR, caloric restriction (or caloric restricted conditions</span><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.5pt"> in vitro</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">); KCRD,</span></p>
<p style="top:520.6pt;left:32.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">ketogenic of caloric restricted diet; KS, ketone supplementation; STS, short-term</span></p>
<p style="top:529.1pt;left:32.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">starvation (or STS-mimicking conditions</span><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.5pt"> in vitro</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">).</span></p>
<p style="top:536.3pt;left:38.7pt;line-height:4.7pt"><span style="font-family:AdvOT863180fb,serif;font-size:4.7pt">a</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt"> Some studies used more than one glioma cell line or KCRD intervention, or</span></p>
<p style="top:546.3pt;left:32.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">reported more than one endpoint, and are thus listed more than once in the table.</span></p>
<p style="top:554.9pt;left:32.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">The numbers behind &apos;Yes&apos; indicate the number of studies that reported a statistically</span></p>
<p style="top:563.4pt;left:32.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">signi</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:6.5pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">cant effect on this endpoint (P</span><span style="font-family:AdvP4C4E74,serif;font-size:6.5pt"> &#xfffd;</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt"> 0.05).</span><span style="font-family:AdvOT863180fb+20,serif;font-size:6.5pt"> &#x2018;</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">No</span><span style="font-family:AdvOT863180fb+20,serif;font-size:6.5pt">&#x2019;</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt"> indicates that the reported effect</span></p>
<p style="top:572.0pt;left:32.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">was not signi</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:6.5pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">cant.</span></p>
<p style="top:490.8pt;left:301.8pt;line-height:6.5pt"><span style="font-family:AdvOTb83ee1dd.B,serif;font-size:6.5pt">Table 2</span></p>
<p style="top:499.4pt;left:301.8pt;line-height:6.5pt"><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.5pt">In vivo</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt"> studies: summary of results for clinically relevant endpoints.</span><sup><span style="font-family:AdvOT863180fb,serif;font-size:4.7pt;color:#0a7fac">a</span></sup></p>
<p style="top:513.5pt;left:410.7pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Signi</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:6.5pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">cant? KD-UR KD-R KS CR STS Total</span></p>
<p style="top:526.6pt;left:307.8pt;line-height:6.5pt"><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.5pt">Decreased tumor growth</span></p>
<p style="top:535.2pt;left:314.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">KCRD intervention only</span></p>
<p style="top:535.2pt;left:410.7pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Yes</span></p>
<p style="top:535.2pt;left:450.0pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">3</span></p>
<p style="top:535.2pt;left:474.3pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">3</span></p>
<p style="top:535.2pt;left:505.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">9</span></p>
<p style="top:535.2pt;left:517.3pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">2</span></p>
<p style="top:535.2pt;left:531.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">17</span></p>
<p style="top:543.8pt;left:410.7pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">No</span></p>
<p style="top:543.8pt;left:450.0pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">4</span></p>
<p style="top:543.8pt;left:474.3pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">1</span></p>
<p style="top:543.8pt;left:505.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">1</span></p>
<p style="top:543.8pt;left:517.3pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">1</span></p>
<p style="top:543.8pt;left:531.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">7</span></p>
<p style="top:552.4pt;left:314.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Combined with chemotherapy Yes</span></p>
<p style="top:552.4pt;left:517.3pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">3</span></p>
<p style="top:552.4pt;left:531.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">3</span></p>
<p style="top:560.9pt;left:314.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Combined with radiotherapy</span></p>
<p style="top:560.9pt;left:410.7pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Yes</span></p>
<p style="top:560.9pt;left:450.0pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">1</span></p>
<p style="top:560.9pt;left:531.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">1</span></p>
<p style="top:569.5pt;left:314.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Combined with HBO</span><span style="font-family:AdvOT863180fb,serif;font-size:4.7pt">2</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">T</span></p>
<p style="top:569.5pt;left:410.7pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Yes</span></p>
<p style="top:569.5pt;left:450.0pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">1</span></p>
<p style="top:569.5pt;left:531.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">1</span></p>
<p style="top:578.1pt;left:314.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Combined with 2-DG</span></p>
<p style="top:578.1pt;left:410.7pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Yes</span></p>
<p style="top:578.1pt;left:450.0pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">1</span></p>
<p style="top:578.1pt;left:531.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">1</span></p>
<p style="top:586.6pt;left:307.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Increased death rates of tumor</span></p>
<p style="top:595.2pt;left:315.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">cells</span></p>
<p style="top:586.6pt;left:410.7pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Yes</span></p>
<p style="top:586.6pt;left:505.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">3</span></p>
<p style="top:586.6pt;left:531.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">3</span></p>
<p style="top:603.7pt;left:307.8pt;line-height:6.5pt"><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.5pt">Increased survival</span></p>
<p style="top:612.4pt;left:314.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">KCRD intervention only</span></p>
<p style="top:612.4pt;left:410.7pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Yes</span></p>
<p style="top:612.4pt;left:450.0pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">5</span></p>
<p style="top:612.4pt;left:474.3pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">1</span></p>
<p style="top:612.4pt;left:493.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">1</span></p>
<p style="top:612.4pt;left:505.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">2</span></p>
<p style="top:612.4pt;left:517.3pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">1</span></p>
<p style="top:612.4pt;left:531.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">10</span></p>
<p style="top:620.9pt;left:410.7pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">No</span></p>
<p style="top:620.9pt;left:450.0pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">3</span></p>
<p style="top:620.9pt;left:474.3pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">1</span></p>
<p style="top:620.9pt;left:505.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">1</span></p>
<p style="top:620.9pt;left:517.3pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">1</span></p>
<p style="top:620.9pt;left:531.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">6</span></p>
<p style="top:629.5pt;left:314.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Combined with chemotherapy Yes</span></p>
<p style="top:629.5pt;left:517.3pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">2</span></p>
<p style="top:629.5pt;left:531.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">2</span></p>
<p style="top:638.0pt;left:314.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Combined with radiotherapy</span></p>
<p style="top:638.0pt;left:410.7pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Yes</span></p>
<p style="top:638.0pt;left:450.0pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">1</span></p>
<p style="top:638.0pt;left:517.3pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">1</span></p>
<p style="top:638.0pt;left:531.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">2</span></p>
<p style="top:646.6pt;left:314.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Combined with bevacizumab</span></p>
<p style="top:646.6pt;left:410.7pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Yes</span></p>
<p style="top:646.6pt;left:450.0pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">1</span></p>
<p style="top:646.6pt;left:531.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">1</span></p>
<p style="top:655.2pt;left:314.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Combined with HBO</span><span style="font-family:AdvOT863180fb,serif;font-size:4.7pt">2</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">T</span></p>
<p style="top:655.2pt;left:410.7pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Yes</span></p>
<p style="top:655.2pt;left:450.0pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">1</span></p>
<p style="top:655.2pt;left:531.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">1</span></p>
<p style="top:668.3pt;left:301.8pt;line-height:6.5pt"><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.5pt">Abbreviations</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">: 2-DG, 2-deoxy-</span><span style="font-family:AdvOT863180fb,serif;font-size:4.6pt">D</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">-glucose; CR, caloric restriction; HBO</span><span style="font-family:AdvOT863180fb,serif;font-size:4.7pt">2</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">T, hyperbaric</span></p>
<p style="top:676.9pt;left:301.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">oxygen therapy; KCRD, ketogenic or caloric restricted diet; KD-R, restricted keto-</span></p>
<p style="top:685.4pt;left:301.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">genic diet; KD-UR, unrestricted ketogenic diet; KS, ketone supplementation; STS,</span></p>
<p style="top:694.0pt;left:301.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">short-term starvation.</span></p>
<p style="top:701.2pt;left:307.7pt;line-height:4.7pt"><span style="font-family:AdvOT863180fb,serif;font-size:4.7pt">a</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt"> Some studies used more than one glioma model or KCRD intervention, or re-</span></p>
<p style="top:711.2pt;left:301.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">ported more than one endpoint, and are thus listed more than once in the table. The</span></p>
<p style="top:719.7pt;left:301.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">numbers behind &apos;Yes&apos; indicate the number of studies that reported a statistically</span></p>
<p style="top:728.3pt;left:301.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">signi</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:6.5pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">cant effect on this endpoint (P</span><span style="font-family:AdvP4C4E74,serif;font-size:6.5pt"> &#xfffd;</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt"> 0.05).</span><span style="font-family:AdvOT863180fb+20,serif;font-size:6.5pt"> &#x2018;</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">No</span><span style="font-family:AdvOT863180fb+20,serif;font-size:6.5pt">&#x2019;</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt"> indicates that the reported effect</span></p>
<p style="top:736.9pt;left:301.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">was not signi</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:6.5pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">cant.</span></p>
<p style="top:47.8pt;left:211.5pt;line-height:6.4pt"><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.4pt">L. Noorlag et al. / Clinical Nutrition 38 (2019) 1986</span><span style="font-family:AdvPS44A44B,serif;font-size:6.4pt">e</span><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.4pt">1994</span></p>
<p style="top:47.8pt;left:32.8pt;line-height:6.4pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.4pt">1988</span></p>


<p style="top:296.7pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">authors reported an increased expression of the tight junction</span></p>
<p style="top:307.2pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">protein zona occludens-1 and a decreased expression of aquaporin-</span></p>
<p style="top:317.7pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">4, which (together with the reduced angiogenesis) seemed to cause</span></p>
<p style="top:328.1pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">a reduction of peritumoral edema. Finally, the concentrations of</span></p>
<p style="top:338.6pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">matrix metalloproteinase-2 and vimentin were decreased. These</span></p>
<p style="top:349.0pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">proteins are hypothesized to contribute to tumor invasiveness</span></p>
<p style="top:359.5pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac">[44,45]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">, and therefore the authors suggest this could be reduced by</span></p>
<p style="top:369.9pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">KDs.</span></p>
<p style="top:380.4pt;left:54.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">Eleven studies with a KD recorded body weight. Seven studies</span></p>
<p style="top:390.9pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">with a KD-UR found no signi</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">cant decrease in body weight</span></p>
<p style="top:401.3pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac">[30,34,37,40</span><span style="font-family:AdvPS44A44B,serif;font-size:8.1pt;color:#0a7fac">e</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac">43]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">. Two studies, however, found weight loss in the</span></p>
<p style="top:411.8pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">KD-UR groups compared with the control groups</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [25,36]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">. As ex-</span></p>
<p style="top:422.3pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">pected, the KD-R mice had weight loss of 10</span><span style="font-family:AdvPS44A44B,serif;font-size:8.1pt">e</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">23% in 7</span><span style="font-family:AdvPS44A44B,serif;font-size:8.1pt">e</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">13 days</span></p>
<p style="top:432.7pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac">[35,38,40,42]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">.</span></p>
<p style="top:443.2pt;left:54.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">Martuscello et al. also studied a protein enriched, supplemented</span></p>
<p style="top:453.6pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">high-fat low-carbohydrate diet, which had similar effects on sur-</span></p>
<p style="top:464.1pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">rogate</span></p>
<p style="top:464.1pt;left:73.1pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">and</span></p>
<p style="top:464.1pt;left:93.9pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">clinically</span></p>
<p style="top:464.1pt;left:134.0pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">relevant</span></p>
<p style="top:464.1pt;left:171.4pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">endpoints</span></p>
<p style="top:464.1pt;left:215.9pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">(decreased</span></p>
<p style="top:464.1pt;left:263.4pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">glucose,</span></p>
<p style="top:474.5pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">increased ketones, reduced tumor growth, and improved survival),</span></p>
<p style="top:485.0pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">but to a lesser extent than the KD-UR</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [36]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">. The only difference was</span></p>
<p style="top:495.5pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">the weight gain in the mice on this new diet, which the authors</span></p>
<p style="top:505.9pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">attributed to its better palatability, compared with the weight loss</span></p>
<p style="top:516.4pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">in the KD-UR mice.</span></p>
<p style="top:542.3pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOTb92eb7df.I,serif;font-size:8.1pt">3.2.2. Ketone supplementation</span></p>
<p style="top:552.8pt;left:54.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">Poff et al. supplied ketones to mice with a subcutaneous model,</span></p>
<p style="top:563.2pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">by adding 1,3-butanediol or a ketone ester to a standard diet</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [26]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">.</span></p>
<p style="top:573.7pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">Survival improved in both groups compared with the control group.</span></p>
<p style="top:584.2pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">Only in the ketone ester-group, blood glucose decreased and ke-</span></p>
<p style="top:594.6pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">tones increased. In addition, only the ketone ester-mice lost body</span></p>
<p style="top:605.1pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">weight, approximately 20%. This was signi</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">cantly associated with</span></p>
<p style="top:615.5pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">increased survival. Because of this</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt"> &#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">nding, Poff et al. discussed the</span></p>
<p style="top:626.0pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">possibility that the improved survival in the ketone ester-group</span></p>
<p style="top:636.4pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">could partly be due to (indirect) CR and not only to KS.</span></p>
<p style="top:662.4pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOTb92eb7df.I,serif;font-size:8.1pt">3.2.3. Caloric restriction</span></p>
<p style="top:672.8pt;left:54.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">Nine studies used 30</span><span style="font-family:AdvPS44A44B,serif;font-size:8.1pt">e</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">40% CR</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [26,31,40,46</span><span style="font-family:AdvPS44A44B,serif;font-size:8.1pt;color:#0a7fac">e</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac">51]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">, and one study</span></p>
<p style="top:683.3pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">alternated days of fasting with 25% CR</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [52]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">.</span></p>
<p style="top:693.8pt;left:54.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">Marsh et al. used a subcutaneous and an intracerebral model</span></p>
<p style="top:704.2pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac">[52]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">, and in both models, tumors grew slower in the CR-group. The</span></p>
<p style="top:714.7pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">study examined survival differences with the subcutaneous model,</span></p>
<p style="top:725.1pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">and found improved survival in the CR-group, compared with the</span></p>
<p style="top:735.6pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">control group.</span></p>
<p style="top:66.1pt;left:323.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">Three studies reported other endpoints in addition to tumor</span></p>
<p style="top:76.5pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">growth; CR led to a decrease in peritumoral edema (possibly due to</span></p>
<p style="top:87.0pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">an increase in tight junctions)</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [46]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">, in in</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb02;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ammation</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [49]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">, and in</span></p>
<p style="top:97.5pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">tumor invasiveness from the hemisphere with tumor cells to the</span></p>
<p style="top:108.0pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">contralateral hemisphere</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [50]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">.</span></p>
<p style="top:118.4pt;left:323.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">Five studies reported antiangiogenic effects, the main ones be-</span></p>
<p style="top:128.9pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ing a decrease in the VEGF concentration</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [46,47,51]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">, a lower tumor</span></p>
<p style="top:139.3pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">microvessel density</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [47,48,50,51]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">, and a shift of immature tumor</span></p>
<p style="top:149.8pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">vessels to a more mature and less leaky state</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [46,51]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">.</span></p>
<p style="top:160.2pt;left:323.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">Body weight was recorded in nine studies</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [26,40,46</span><span style="font-family:AdvPS44A44B,serif;font-size:8.1pt;color:#0a7fac">e</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac">52]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">. As</span></p>
<p style="top:170.7pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">expected, body weight decreased during periods of CR in all, with</span></p>
<p style="top:181.1pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">weight loss of 10</span><span style="font-family:AdvPS44A44B,serif;font-size:8.1pt">e</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">22% in 7</span><span style="font-family:AdvPS44A44B,serif;font-size:8.1pt">e</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">15 days compared with baseline body</span></p>
<p style="top:191.6pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">weight in</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt"> &#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ve</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [26,40,47,48,51]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">, and weight loss of 23.9</span><span style="font-family:AdvPS44A44B,serif;font-size:8.1pt">e</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">30% in</span></p>
<p style="top:202.1pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">14</span><span style="font-family:AdvPS44A44B,serif;font-size:8.1pt">e</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">18 days compared with controls in three</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [46,49,52]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">. One study</span></p>
<p style="top:212.6pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">did not report the percentage of weight loss</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [50]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">.</span></p>
<p style="top:233.5pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOTb92eb7df.I,serif;font-size:8.1pt">3.2.4. Short-term starvation (STS)</span></p>
<p style="top:243.9pt;left:323.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">Two studies implemented STS</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [29,33]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">. STS induced signi</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">cant</span></p>
<p style="top:254.4pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">weight loss in both</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [29,33]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">, but the mice rapidly regained their</span></p>
<p style="top:264.8pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">initial body weight.</span></p>
<p style="top:275.3pt;left:323.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">Lee et al. used a subcutaneous model, and starved mice for 48 h,</span></p>
<p style="top:285.8pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">in one group concomitantly with administration of doxorubicin</span></p>
<p style="top:296.2pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac">[29]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">. Tumor growth decreased synergistically when both STS and</span></p>
<p style="top:306.7pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">doxorubicin were used.</span></p>
<p style="top:317.2pt;left:323.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">Safdie et al. studied STS in a subcutaneous and an intracerebral</span></p>
<p style="top:327.6pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">model</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [33]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">. The animals with the subcutaneous model were</span></p>
<p style="top:338.1pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">withdrawn of food for two 48 h cycles, and those with the intra-</span></p>
<p style="top:348.6pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">cerebral model all fasted for one 48 h cycle and partly for an</span></p>
<p style="top:359.0pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">additional 24 h. In the subcutaneous model, STS alone reduced</span></p>
<p style="top:369.5pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">tumor growth and improved survival, but temozolomide and</span></p>
<p style="top:379.9pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">radiotherapy alone did not. Combining STS with each of these</span></p>
<p style="top:390.4pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">standard treatments had synergistic effects on tumor growth and</span></p>
<p style="top:400.8pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">survival. In the intracerebral model mice that fasted for 48 h, sig-</span></p>
<p style="top:411.3pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ni</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">cant effects on tumor growth and survival were found in the</span></p>
<p style="top:421.8pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">group with both STS and temozolomide, but not with STS or</span></p>
<p style="top:432.2pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">temozolomide alone. In the intracerebral model mice that fasted</span></p>
<p style="top:442.7pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">the additional 24 h, decreased tumor growth and improved survival</span></p>
<p style="top:453.2pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">were reported in the group with temozolomide alone and the</span></p>
<p style="top:463.6pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">group with both STS and temozolomide, but not in the group with</span></p>
<p style="top:474.1pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">STS alone.</span></p>
<p style="top:495.0pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOTb92eb7df.I,serif;font-size:8.1pt">3.3. Associations between endpoints</span></p>
<p style="top:515.9pt;left:323.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">Thirteen of the sixteen studies reporting a signi</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">cant decrease</span></p>
<p style="top:526.3pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">in blood glucose found positive effects on tumor growth or survival.</span></p>
<p style="top:536.8pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">Two studies did not report a decrease in glucose and did not</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt"> &#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">nd</span></p>
<p style="top:547.3pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">reduced tumor growth or improved survival. We found a trend</span></p>
<p style="top:557.8pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">towards an association between decreased glucose and the clini-</span></p>
<p style="top:568.2pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">cally relevant endpoints tumor growth and survival (P</span><span style="font-family:AdvP4C4E74,serif;font-size:8.1pt"> &#xbc;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> 0.07,</span></p>
<p style="top:578.7pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">Phi</span><span style="font-family:AdvP4C4E74,serif;font-size:8.1pt"> &#xbc;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> 0.57, Fisher&apos;s exact test).</span></p>
<p style="top:589.1pt;left:323.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">Thirteen studies reported a signi</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">cant increase in blood ke-</span></p>
<p style="top:599.6pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">tones, and nine of these reported decreased tumor growth or</span></p>
<p style="top:610.0pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">increased survival. One study reported no increase in ketones, but</span></p>
<p style="top:620.5pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">nevertheless found improved survival. No association was found</span></p>
<p style="top:630.9pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">between ketones and tumor growth or survival (P</span><span style="font-family:AdvP4C4E74,serif;font-size:8.1pt"> &#xbc;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> 1.0).</span></p>
<p style="top:651.9pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOTb92eb7df.I,serif;font-size:8.1pt">3.4. Molecular-biological pathways and mechanisms</span></p>
<p style="top:672.8pt;left:323.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">Ten studies described molecular-biological effects of KCRDs on</span></p>
<p style="top:683.3pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">gliomas. Three studies examined the hypothesis that glioma cells</span></p>
<p style="top:693.8pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">are less able to use ketones as their primary energy source than</span></p>
<p style="top:704.2pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">normal brain cells</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [30,35,42]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">. One study found a decreased</span></p>
<p style="top:714.7pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">expression of ketolytic enzymes in glioma tissue (CT-2A and U87-</span></p>
<p style="top:725.1pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">MG) compared with normal brain tissue</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [42]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">. In contrast, another</span></p>
<p style="top:735.6pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">study found that these enzymes were expressed at mRNA and</span></p>
<p style="top:66.2pt;left:42.5pt;line-height:6.5pt"><span style="font-family:AdvOTb83ee1dd.B,serif;font-size:6.5pt">Table 3</span></p>
<p style="top:74.8pt;left:42.5pt;line-height:6.5pt"><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.5pt">In vivo</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt"> studies: summary of results for surrogate endpoints.</span><sup><span style="font-family:AdvOT863180fb,serif;font-size:4.7pt;color:#0a7fac">a</span></sup></p>
<p style="top:89.0pt;left:126.4pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Signi</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:6.5pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">cant?</span></p>
<p style="top:89.0pt;left:169.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">KD-UR</span></p>
<p style="top:89.0pt;left:198.3pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">KD-R</span></p>
<p style="top:89.0pt;left:222.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">KS</span></p>
<p style="top:89.0pt;left:237.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">CR</span></p>
<p style="top:89.0pt;left:253.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">STS</span></p>
<p style="top:89.0pt;left:272.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Total</span></p>
<p style="top:102.1pt;left:48.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Decreased glucose</span></p>
<p style="top:102.1pt;left:126.4pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Yes</span></p>
<p style="top:102.1pt;left:169.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">5</span></p>
<p style="top:102.1pt;left:198.3pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">3</span></p>
<p style="top:102.1pt;left:222.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">1</span></p>
<p style="top:102.1pt;left:237.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">8</span></p>
<p style="top:102.1pt;left:253.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">2</span></p>
<p style="top:102.1pt;left:272.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">19</span></p>
<p style="top:110.7pt;left:126.4pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">No</span></p>
<p style="top:110.7pt;left:169.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">4</span></p>
<p style="top:110.7pt;left:222.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">1</span></p>
<p style="top:110.7pt;left:272.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">5</span></p>
<p style="top:119.2pt;left:48.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Increased ketones</span></p>
<p style="top:119.2pt;left:126.4pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Yes</span></p>
<p style="top:119.2pt;left:169.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">9</span></p>
<p style="top:119.2pt;left:198.3pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">3</span></p>
<p style="top:119.2pt;left:222.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">1</span></p>
<p style="top:119.2pt;left:237.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">5</span></p>
<p style="top:119.2pt;left:272.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">18</span></p>
<p style="top:127.8pt;left:126.4pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">No</span></p>
<p style="top:127.8pt;left:169.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">1</span></p>
<p style="top:127.8pt;left:222.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">1</span></p>
<p style="top:127.8pt;left:272.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">2</span></p>
<p style="top:136.4pt;left:48.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Decreased IGF-I</span></p>
<p style="top:136.4pt;left:126.4pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Yes</span></p>
<p style="top:136.4pt;left:198.3pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">1</span></p>
<p style="top:136.4pt;left:237.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">4</span></p>
<p style="top:136.4pt;left:253.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">1</span></p>
<p style="top:136.4pt;left:272.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">6</span></p>
<p style="top:144.9pt;left:126.4pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">No</span></p>
<p style="top:144.9pt;left:169.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">2</span></p>
<p style="top:144.9pt;left:272.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">2</span></p>
<p style="top:153.5pt;left:48.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Antiangiogenic effects</span><sup><span style="font-family:AdvOT863180fb,serif;font-size:4.7pt;color:#0a7fac">b</span></sup></p>
<p style="top:153.5pt;left:126.4pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Yes</span></p>
<p style="top:153.5pt;left:169.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">1</span></p>
<p style="top:153.5pt;left:198.3pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">1</span></p>
<p style="top:153.5pt;left:237.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">5</span></p>
<p style="top:153.5pt;left:272.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">7</span></p>
<p style="top:162.1pt;left:126.4pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">No</span></p>
<p style="top:162.1pt;left:169.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">1</span></p>
<p style="top:162.1pt;left:272.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">1</span></p>
<p style="top:175.3pt;left:42.5pt;line-height:6.5pt"><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.5pt">Abbreviations</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">: CR, caloric restriction; IGF-I, insulin-like growth factor I; KD-R,</span></p>
<p style="top:183.8pt;left:42.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">restricted ketogenic diet; KD-UR, unrestricted ketogenic diet; KS, ketone supple-</span></p>
<p style="top:192.4pt;left:42.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">mentation; STS, short-term starvation.</span></p>
<p style="top:199.5pt;left:48.4pt;line-height:4.7pt"><span style="font-family:AdvOT863180fb,serif;font-size:4.7pt">a</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt"> Some studies used more than one glioma model or KCRD intervention, or re-</span></p>
<p style="top:209.5pt;left:42.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">ported more than one endpoint, and are thus listed more than once in the table. The</span></p>
<p style="top:218.1pt;left:42.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">numbers behind &apos;Yes&apos; indicate the number of studies that reported a statistically</span></p>
<p style="top:226.6pt;left:42.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">signi</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:6.5pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">cant effect on this endpoint (P</span><span style="font-family:AdvP4C4E74,serif;font-size:6.5pt"> &#xfffd;</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt"> 0.05).</span><span style="font-family:AdvOT863180fb+20,serif;font-size:6.5pt"> &#x2018;</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">No</span><span style="font-family:AdvOT863180fb+20,serif;font-size:6.5pt">&#x2019;</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt"> indicates that the reported effect</span></p>
<p style="top:235.2pt;left:42.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">was not signi</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:6.5pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">cant.</span></p>
<p style="top:242.4pt;left:48.1pt;line-height:4.7pt"><span style="font-family:AdvOT863180fb,serif;font-size:4.7pt">b</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt"> Antiangiogenic effects include a decrease in the vascular endothelial growth</span></p>
<p style="top:252.4pt;left:42.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">factor (VEGF) concentration or the VEGF-receptor-2 (VEGFR2) expression, a lower</span></p>
<p style="top:260.9pt;left:42.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">tumor microvessel density, and the shift of immature tumor vessels to a more</span></p>
<p style="top:269.5pt;left:42.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">mature and less leaky state.</span></p>
<p style="top:47.8pt;left:221.2pt;line-height:6.4pt"><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.4pt">L. Noorlag et al. / Clinical Nutrition 38 (2019) 1986</span><span style="font-family:AdvPS44A44B,serif;font-size:6.4pt">e</span><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.4pt">1994</span></p>
<p style="top:47.8pt;left:548.3pt;line-height:6.4pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.4pt">1989</span></p>


<p style="top:66.1pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">protein levels in the studied glioma cell lines (T98G, U87MG, A172,</span></p>
<p style="top:76.6pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">LNT-229, and U251MG), and that the expressions did not change</span></p>
<p style="top:87.0pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">with KS</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [30]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">. However, these enzymes were not able to metabolize</span></p>
<p style="top:97.5pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">the ketone body</span><span style="font-family:AdvP3F4C13,serif;font-size:8.7pt"> b</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">-hydroxybutyrate. Finally, De Feyter et al. studied</span></p>
<p style="top:108.0pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">tumor metabolism both</span><span style="font-family:AdvOTb92eb7df.I,serif;font-size:8.1pt"> in vitro</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> and</span><span style="font-family:AdvOTb92eb7df.I,serif;font-size:8.1pt"> in vivo</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> and found con</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb02;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">icting</span></p>
<p style="top:118.4pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">results</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [35]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">.</span><span style="font-family:AdvOTb92eb7df.I,serif;font-size:8.1pt"> In vitro</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">,</span><span style="font-family:AdvP3F4C13,serif;font-size:8.7pt"> b</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">-hydroxybutyrate uptake and oxidation in the</span></p>
<p style="top:128.9pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">glioma cells (RG2 and 9L) were low to undetectable in a low-</span></p>
<p style="top:139.3pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">glucose high-ketone body medium.</span><span style="font-family:AdvOTb92eb7df.I,serif;font-size:8.1pt"> In vivo</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">, however,</span><span style="font-family:AdvP3F4C13,serif;font-size:8.7pt"> b</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">-hydrox-</span></p>
<p style="top:149.8pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ybutyrate uptake and oxidation were similar in glioma tissue and</span></p>
<p style="top:160.2pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">contralateral brain when this ketone body was infused, with</span></p>
<p style="top:170.7pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">increased uptake in glioma tissue of mice on a KD, leading to</span></p>
<p style="top:181.2pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">comparable oxidation in glioma tissue and contralateral brain. The</span></p>
<p style="top:191.6pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">authors could not</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt"> &#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">nd an explanation for the difference between</span></p>
<p style="top:202.1pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">the</span><span style="font-family:AdvOTb92eb7df.I,serif;font-size:8.1pt"> in vitro</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> and</span><span style="font-family:AdvOTb92eb7df.I,serif;font-size:8.1pt"> in vivo</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> results.</span></p>
<p style="top:212.6pt;left:44.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">One study described the proapoptotic effects of CR, with use of a</span></p>
<p style="top:223.0pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">CT-2A glioma model</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [52]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">. This model is characterized by constitu-</span></p>
<p style="top:233.5pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">tive phosphorylation of Akt due to decreased expression of phos-</span></p>
<p style="top:243.9pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">phatase and tensin homologue (PTEN) tumor suppressor, and is</span></p>
<p style="top:254.4pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">de</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">cient for tuberous sclerosis complex 2 (TSC2). In addition, the</span></p>
<p style="top:264.8pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">expression of insulin-like growth factor I (IGF-I) and its receptor</span></p>
<p style="top:275.3pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">(IGF-IR) is signi</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">cantly higher than in normal brain cells, which</span></p>
<p style="top:285.8pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">results in a dependency of CT-2A gliomas on glycolysis. These</span></p>
<p style="top:296.2pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">mutations in the PTEN/Akt/TSC2 pathway cause the antiapoptotic</span></p>
<p style="top:306.7pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">phenotype of CT-2A gliomas, but make tumors unable to adapt to</span></p>
<p style="top:317.2pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ketosis. Moreover, CR lowers the expression of IGF-I and IGF-IR, and</span></p>
<p style="top:327.6pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">thus downregulates glycolysis. These effects subsequently result in</span></p>
<p style="top:338.1pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">increased cell death of CT-2A gliomas.</span></p>
<p style="top:348.6pt;left:44.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">Mukherjee et al. found that glucose withdrawal (</span><span style="font-family:AdvOTb92eb7df.I,serif;font-size:8.1pt">in vitro</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">) and CR</span></p>
<p style="top:359.0pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">(</span><span style="font-family:AdvOTb92eb7df.I,serif;font-size:8.1pt">in vivo</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">) cause an increase in phosphorylation of AMP-activated</span></p>
<p style="top:369.5pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">protein kinase (AMPK) in CT-2A glioma cell lines and models,</span></p>
<p style="top:379.9pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">respectively, compared with normal brain cells</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [31]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">. Increased</span></p>
<p style="top:390.4pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">AMPK phosphorylation leads to inef</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">cient cell signaling in the</span></p>
<p style="top:400.8pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">downstream TSC2-mTOR pathway, and subsequently to increased</span></p>
<p style="top:411.3pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">cell death.</span></p>
<p style="top:421.8pt;left:44.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">Mulrooney et al. describe the effects of CR on the constitutive</span></p>
<p style="top:432.2pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">activation of the NF-kB pathway in a CT-2A glioma model</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [49]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">. CR</span></p>
<p style="top:442.7pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">reduces phosphorylation and activation of genes dependent on this</span></p>
<p style="top:453.2pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">pathway, and expression of downstream proin</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb02;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ammatory markers.</span></p>
<p style="top:463.6pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">By this, the authors conclude that CR reduces the in</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb02;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ammatory</span></p>
<p style="top:474.1pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">response of CT-2A gliomas, and thus inhibits angiogenesis, peritu-</span></p>
<p style="top:484.5pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">moral edema and tumor progression, since these processes are</span></p>
<p style="top:495.0pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">stimulated by in</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb02;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ammation.</span></p>
<p style="top:505.4pt;left:44.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">Woolf et al. used a GL261 glioma model and found no difference</span></p>
<p style="top:515.9pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">in total NF-kB expression between the KD-UR group and control</span></p>
<p style="top:526.3pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">group</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [41]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">. However, phosphorylated NF-kB was signi</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">cantly</span></p>
<p style="top:536.8pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">reduced, and this suggests reduced activation of the NF-kB</span></p>
<p style="top:547.3pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">pathway. In addition, the authors studied the effect of a KD on</span></p>
<p style="top:557.8pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">hypoxia in tumors, by measuring hypoxia inducible factor-1</span><span style="font-family:AdvP3F4C13,serif;font-size:8.7pt">a</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> (HIF-</span></p>
<p style="top:568.2pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">1</span><span style="font-family:AdvP3F4C13,serif;font-size:8.7pt">a</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">) and carbonic anhydrase IX. Carbonic anhydrase IX is controlled</span></p>
<p style="top:578.7pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">by HIF-1</span><span style="font-family:AdvP3F4C13,serif;font-size:8.7pt">a</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">, and HIF-1</span><span style="font-family:AdvP3F4C13,serif;font-size:8.7pt">a</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> stimulates angiogenesis and tumor inva-</span></p>
<p style="top:589.1pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">siveness. Both expressions were signi</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">cantly reduced in tumors of</span></p>
<p style="top:599.6pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">the KD-group, and this led to the hypothesis that hypoxia in tumors</span></p>
<p style="top:610.0pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">could be reduced with a KD.</span></p>
<p style="top:620.5pt;left:44.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">The same research group studied the effects of a KD-UR on the</span></p>
<p style="top:631.0pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">glioma-mediated immune suppression and tumor-reactive im-</span></p>
<p style="top:641.4pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">mune response in the GL261 glioma model</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [43]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">. On the one hand,</span></p>
<p style="top:651.9pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">KD-UR mice expressed signi</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">cantly less immune inhibitory re-</span></p>
<p style="top:662.4pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ceptors and ligands in tumors. On the other hand, an increase in</span></p>
<p style="top:672.8pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">CD4</span><span style="font-family:AdvP4C4E74,serif;font-size:8.1pt">&#xfe;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> Tcells, in cytokine production (such as interferon gamma and</span></p>
<p style="top:683.3pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">tumor necrosis factor) of CD8</span><span style="font-family:AdvP4C4E74,serif;font-size:8.1pt">&#xfe;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> T cells and natural killer cells, and in</span></p>
<p style="top:693.8pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">cytotoxic capability of CD8</span><span style="font-family:AdvP4C4E74,serif;font-size:8.1pt">&#xfe;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> T cells was found in KD-UR mice. This</span></p>
<p style="top:704.2pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">study thus suggests an effect of a KD on the immune response</span></p>
<p style="top:714.7pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">against gliomas.</span></p>
<p style="top:725.1pt;left:44.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">Flavahan et al. studied the effects of glucose restriction on brain</span></p>
<p style="top:735.6pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">tumor initiating cells (BTICs)</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [28]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">. The authors found that BTICs</span></p>
<p style="top:66.1pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">preferentially survive</span><span style="font-family:AdvOTb92eb7df.I,serif;font-size:8.1pt"> in vitro</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> when glucose is restricted, compared</span></p>
<p style="top:76.5pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">with non-BTICs. In addition, non-BTICs that survive low glucose</span></p>
<p style="top:87.0pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">conditions acquire characteristics of BTICs. Moreover, when glio-</span></p>
<p style="top:97.5pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">blastoma cells are cultured in low glucose conditions, and subse-</span></p>
<p style="top:108.0pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">quently implanted</span><span style="font-family:AdvOTb92eb7df.I,serif;font-size:8.1pt"> in vivo</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">, the resulting tumors grow signi</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">cantly</span></p>
<p style="top:118.4pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">faster than those cultured in normal glucose conditions. This</span></p>
<p style="top:128.9pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">resulted in lower median survival. Because of these</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt"> &#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ndings, the</span></p>
<p style="top:139.3pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">authors conclude that lowering glucose through KCRDs could lead</span></p>
<p style="top:149.8pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">to tumor progression instead of regression.</span></p>
<p style="top:160.2pt;left:313.7pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">Stafford et al. found that a KD results in improved survival, as</span></p>
<p style="top:170.7pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">well as in an overall change in gene expression patterns of GL261</span></p>
<p style="top:181.1pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">glioma cells, with a shift towards the patterns found in normal</span></p>
<p style="top:191.6pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">brain cells, particularly of genes involved in oxidative stress re-</span></p>
<p style="top:202.1pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">sponses</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [34]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">. Reactive oxygen species signi</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">cantly decreased</span></p>
<p style="top:212.6pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOTb92eb7df.I,serif;font-size:8.1pt">in vitro</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> with KS and</span><span style="font-family:AdvOTb92eb7df.I,serif;font-size:8.1pt"> in vivo</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> with a KD (</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac">Supplemental Table 4</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">), and</span></p>
<p style="top:223.0pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">the authors suggested that this may have caused the improved</span></p>
<p style="top:233.5pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">survival.</span></p>
<p style="top:255.5pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOTb92eb7df.I,serif;font-size:8.1pt">3.5. Clinical studies</span></p>
<p style="top:276.4pt;left:313.7pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">We included eight clinical studies, consisting of three cohort</span></p>
<p style="top:286.9pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">studies</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [39,53,54]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">, four case reports</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [27,55</span><span style="font-family:AdvPS44A44B,serif;font-size:8.1pt;color:#0a7fac">e</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac">57]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> and one clinical</span></p>
<p style="top:297.3pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">abstract</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [58]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">. For study characteristics, see</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> Supplemental Table 3</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">.</span></p>
<p style="top:319.4pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOTb92eb7df.I,serif;font-size:8.1pt">3.5.1. Quality assessment</span></p>
<p style="top:329.8pt;left:313.7pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">The results of the quality assessment of the clinical studies are</span></p>
<p style="top:340.3pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">shown in</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> Fig. 2</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">. We used all components of the Cochrane Collab-</span></p>
<p style="top:350.8pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">oration&apos;s tool for assessing risk of bias</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [24]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">. Blinding of outcome</span></p>
<p style="top:361.2pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">assessment was not done for any of the endpoints. As described</span></p>
<p style="top:371.7pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">previously, we assessed incomplete outcome data separately for</span></p>
<p style="top:382.1pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">laboratory effects, tumor growth, survival (essential parameters),</span></p>
<p style="top:392.6pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">safety and feasibility and quality of life (non-essential parameters).</span></p>
<p style="top:403.0pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">We found a high risk of attrition bias due to incomplete outcome</span></p>
<p style="top:413.5pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">assessment for survival and laboratory effects in multiple studies.</span></p>
<p style="top:424.0pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">Because of the uncontrolled study designs, the lack of blinding in all</span></p>
<p style="top:434.4pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">studies and the high risk of attrition bias, we consider the overall</span></p>
<img style="position:absolute;transform:matrix(.319947,0,-0,.32000003,55.021974,281.58003)" src="data:image/jpeg;base64,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">
<p style="top:711.3pt;left:301.8pt;line-height:6.4pt"><span style="font-family:AdvOTb83ee1dd.B,serif;font-size:6.4pt">Fig. 2.</span><span style="font-family:AdvOT863180fb,serif;font-size:6.4pt"> Quality assessment of clinical studies was performed with use of the Cochrane</span></p>
<p style="top:719.8pt;left:301.8pt;line-height:6.4pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.4pt">Collaboration&apos;s tool for assessing risk of bias</span><span style="font-family:AdvOT863180fb,serif;font-size:6.4pt;color:#0a7fac"> [24]</span><span style="font-family:AdvOT863180fb,serif;font-size:6.4pt">.</span><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.4pt"> Legend</span><span style="font-family:AdvOT863180fb,serif;font-size:6.4pt">:</span><span style="font-family:AdvP4C4E74,serif;font-size:6.4pt"> &#xfe;</span><span style="font-family:AdvOT863180fb,serif;font-size:6.4pt">, low risk of bias;</span><span style="font-family:AdvP4C4E74,serif;font-size:6.4pt"> &#xfffd;</span><span style="font-family:AdvOT863180fb,serif;font-size:6.4pt">, high</span></p>
<p style="top:728.4pt;left:301.8pt;line-height:6.4pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.4pt">risk of bias; ?, unclear risk of bias; NA, not applicable. Of note, incomplete outcome</span></p>
<p style="top:737.0pt;left:301.8pt;line-height:6.4pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.4pt">data was assessed separately for 5 endpoints.</span></p>
<p style="top:47.8pt;left:211.5pt;line-height:6.4pt"><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.4pt">L. Noorlag et al. / Clinical Nutrition 38 (2019) 1986</span><span style="font-family:AdvPS44A44B,serif;font-size:6.4pt">e</span><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.4pt">1994</span></p>
<p style="top:47.8pt;left:32.8pt;line-height:6.4pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.4pt">1990</span></p>


<p style="top:66.1pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">risk of bias to be high. Many of these sources of bias are inherent to</span></p>
<p style="top:76.6pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">the study designs (two small prospective cohort studies, but mainly</span></p>
<p style="top:87.0pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">case reports).</span></p>
<p style="top:108.0pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOTb92eb7df.I,serif;font-size:8.1pt">3.5.2. Outcome</span></p>
<p style="top:118.4pt;left:54.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">Categorization and statistical analyses were not possible due to</span></p>
<p style="top:128.9pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">the small sample sizes and the heterogeneity of the clinical studies.</span></p>
<p style="top:139.3pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">Therefore, a short description of each study is given below.</span></p>
<p style="top:149.8pt;left:54.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">In a prospective cohort study, a KD-UR was implemented in 20</span></p>
<p style="top:160.2pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">patients with recurrent glioblastomas</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [39]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">. Data collection was</span></p>
<p style="top:170.7pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">completed in thirteen patients, and eight of them (62%) reached</span></p>
<p style="top:181.1pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ketosis, de</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ned as urine ketones</span><span style="font-family:AdvOTb0c9bf5d,serif;font-size:8.1pt"> &gt;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">0.5 mmol/L in</span><span style="font-family:AdvOTb0c9bf5d,serif;font-size:8.1pt"> &gt;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">50% of the urine</span></p>
<p style="top:191.6pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">samples, and these patients had a modest, non-signi</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">cant increase</span></p>
<p style="top:202.1pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">of progression-free survival (PFS) (P</span><span style="font-family:AdvP4C4E74,serif;font-size:8.1pt"> &#xbc;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> 0.07), compared with those</span></p>
<p style="top:212.6pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">without ketosis (6 weeks and 3 weeks, respectively). The mean</span></p>
<p style="top:223.0pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">blood glucose concentration did not decrease signi</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">cantly. All pa-</span></p>
<p style="top:233.5pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">tients progressed while they were on the KD-UR, and nine stopped</span></p>
<p style="top:243.9pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">the diet. Seven continued the diet concomitantly with bev-</span></p>
<p style="top:254.4pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">acizumab. In six of them (85%), the tumor regressed, and they had a</span></p>
<p style="top:264.8pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">median PFS of 20.1 weeks. These results did not differ signi</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">cantly</span></p>
<p style="top:275.3pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">from a cohort of historic controls, treated with bevacizumab alone</span></p>
<p style="top:285.8pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">in whom 65% responded (P</span><span style="font-family:AdvP4C4E74,serif;font-size:8.1pt"> &#xbc;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> 0.4), with a median PFS of 16.1 weeks</span></p>
<p style="top:296.2pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">(P</span><span style="font-family:AdvP4C4E74,serif;font-size:8.1pt"> &#xbc;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> 0.38).</span></p>
<p style="top:306.7pt;left:54.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">Another prospective cohort study implemented a KD in 4</span></p>
<p style="top:317.2pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">recurrent glioblastoma patients, who were concomitantly treated</span></p>
<p style="top:327.6pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">with bevacizumab and corticosteroids</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [54]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">. They had a PFS of 2.5</span></p>
<p style="top:338.1pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">months (2, 4, 0 and 2 months), which was not superior to 4</span></p>
<p style="top:348.6pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">recurrent glioblastoma patients on a standard diet and temozolo-</span></p>
<p style="top:359.0pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">mide, bevacizumab or rindopepimut (PFS of 4 months in two pa-</span></p>
<p style="top:369.5pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">tients, and ongoing at 14 and 24 months in two patients). Another</span></p>
<p style="top:379.9pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">patient with gliomatosis cerebri (with low grade glioma histology)</span></p>
<p style="top:390.4pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">had been stable for 31 months with the KD as monotherapy at the</span></p>
<p style="top:400.8pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">time of publication. Ketosis, based on urine ketones, was only</span></p>
<p style="top:411.3pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">achieved in this patient and one recurrent glioblastoma patient.</span></p>
<p style="top:421.8pt;left:54.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">A retrospective cohort study compared 53 patients with ma-</span></p>
<p style="top:432.2pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">lignant gliomas, of whom six were on a KD and the others on an</span></p>
<p style="top:442.7pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">unspeci</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ed standard diet</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [53]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">. The KD was initiated by the patients,</span></p>
<p style="top:453.2pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">at different time points during standard treatments. All patients</span></p>
<p style="top:463.6pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">were treated with concomitant chemoradiation and adjuvant</span></p>
<p style="top:474.1pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">chemotherapy. The KD signi</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">cantly reduced the mean blood</span></p>
<p style="top:484.5pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">glucose concentration (P</span><span style="font-family:AdvP4C4E74,serif;font-size:8.1pt"> &#xbc;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> 0.02), even in three patients with high</span></p>
<p style="top:495.0pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">dose corticosteroids. Ketosis was con</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">rmed in all patients on the</span></p>
<p style="top:505.4pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">KD. Four were alive at a median follow-up of 14 months, with a</span></p>
<p style="top:515.9pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">median time to disease progression or recurrence of 10 months.</span></p>
<p style="top:526.3pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">These results have not been compared with the control group, nor</span></p>
<p style="top:536.8pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">to historic controls.</span></p>
<p style="top:547.3pt;left:54.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">The</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt"> &#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">rst case report described two pediatric patients with</span></p>
<p style="top:557.8pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">advanced malignant gliomas, who were treated for eight weeks</span></p>
<p style="top:568.2pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">with a diet consisting of 60% medium chain triglyceride oil, 10%</span></p>
<p style="top:578.7pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">carbohydrate, 20% protein and 10% fat</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [55]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">. After eight weeks, PET</span></p>
<p style="top:589.1pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">scans showed a mean reduction of 21.8% in the tumors</span><span style="font-family:AdvOT863180fb+20,serif;font-size:8.1pt">&#x2019;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> glucose</span></p>
<p style="top:599.6pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">uptake. Blood glucose concentrations were low-normal and ke-</span></p>
<p style="top:610.0pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">tones increased 20 to 30 times. When the case report was pub-</span></p>
<p style="top:620.5pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">lished, the patients remained without disease recurrence and with</span></p>
<p style="top:631.0pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">good quality of life for 5 and 4 years.</span></p>
<p style="top:641.4pt;left:54.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">The second case report described regression of a glioblastoma</span></p>
<p style="top:651.9pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">within 2.5 months in a 65-year old female, who was treated with</span></p>
<p style="top:662.4pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">fasting and caloric restricted (ketogenic) diets before, during and</span></p>
<p style="top:672.8pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">after chemoradiation</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [56]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">. Blood glucose decreased and urine ke-</span></p>
<p style="top:683.3pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">tones were 2.5 mmol/L. The tumor recurred ten weeks after dis-</span></p>
<p style="top:693.8pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">continuing CR.</span></p>
<p style="top:704.2pt;left:54.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">Another case report described a 40-year old male with a pro-</span></p>
<p style="top:714.7pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">gressive glioblastoma after standard and antiangiogenic treat-</span></p>
<p style="top:725.1pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ments, in whom a KD-R was implemented concomitantly with</span></p>
<p style="top:735.6pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">bevacizumab</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [27]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">. The tumor remained stable for four months,</span></p>
<p style="top:66.1pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">with blood glucose and ketones of respectively 55</span><span style="font-family:AdvPS44A44B,serif;font-size:8.1pt">e</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">70 mg/dL and</span></p>
<p style="top:76.6pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">4 mmol/L.</span></p>
<p style="top:87.0pt;left:323.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">The last published case report described the effects of a 12-week</span></p>
<p style="top:97.5pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">KD-R (after a 48-h fast to initiate ketosis) in two adult males with</span></p>
<p style="top:108.0pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">recurrent glioblastomas</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [57]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">. The protocol de</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ned optimal blood</span></p>
<p style="top:118.4pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">glucose as 50</span><span style="font-family:AdvPS44A44B,serif;font-size:8.1pt">e</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">70 mg/dL and optimal blood ketones as 3</span><span style="font-family:AdvPS44A44B,serif;font-size:8.1pt">e</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">8 mmol/L.</span></p>
<p style="top:128.9pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">A 55-year-old male initially reached these concentrations, until he</span></p>
<p style="top:139.3pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">changed to a regular foods KD-R due to the low palatability of the</span></p>
<p style="top:149.8pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">original KD-R (KetoCal</span><span style="font-family:AdvTT5843c571,serif;font-size:8.1pt">&#xae;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">). He withdrew from the study when tumor</span></p>
<p style="top:160.2pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">progression was diagnosed after four weeks. A 52-year-old male</span></p>
<p style="top:170.7pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">maintained ketosis during the 12 weeks, with glucose less than</span></p>
<p style="top:181.1pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">100 mg/dL most of the time. His tumor was stable at six weeks, but</span></p>
<p style="top:191.6pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">progressed at 12 weeks.</span></p>
<p style="top:202.1pt;left:323.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">Finally, a clinical abstract described a 7-year-old girl with a</span></p>
<p style="top:212.6pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">glioblastoma, who was treated with a KD during and after che-</span></p>
<p style="top:223.0pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">moradiation</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [58]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">. Glucose decreased and ketosis was reached</span></p>
<p style="top:233.5pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">(blood ketones 2.75</span><span style="font-family:AdvPS44A44B,serif;font-size:8.1pt">e</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">10.16 mmol/L), and tumor size was reduced at</span></p>
<p style="top:243.9pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">10 and 16 weeks.</span></p>
<p style="top:264.8pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOTb92eb7df.I,serif;font-size:8.1pt">3.5.3. Safety, feasibility and adverse effects</span></p>
<p style="top:275.3pt;left:323.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">KCRDs seem to be safe and feasible in the preliminary clinical</span></p>
<p style="top:285.8pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">data to date, even when standard treatments are used concomi-</span></p>
<p style="top:296.2pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">tantly. No serious adverse effects were reported, except for grade II</span></p>
<p style="top:306.7pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">fatigue in a patient who was on a KD with 30% CR</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [53]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">. In the same</span></p>
<p style="top:317.2pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">study, weight loss was described as minimal, except in the above</span></p>
<p style="top:327.6pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">mentioned patient and another who intentionally lost weight. Four</span></p>
<p style="top:338.1pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">patients in the prospective cohort studies discontinued the KCRD</span></p>
<p style="top:348.6pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac">[39,54]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">, because they felt it reduced their quality of life</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [39]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">. In the</span></p>
<p style="top:359.0pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">other 17 patients on the KD-UR, Rieger et al. reported a statistically</span></p>
<p style="top:369.5pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">but not clinically signi</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">cant weight loss of 2.2%. The body weight of</span></p>
<p style="top:379.9pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">the two pediatric patients stabilized, and quality of life improved in</span></p>
<p style="top:390.4pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">one of them, based on the development of skills and an improved</span></p>
<p style="top:400.8pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">mood</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [55]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">. The patient of Zuccoli et al. lost 20% of her body weight,</span></p>
<p style="top:411.3pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">but nevertheless maintained a Karnofsky performance status of</span></p>
<p style="top:421.7pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">100%</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [56]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">. Schwartz et al. reported that their patients lost 6% and 7%</span></p>
<p style="top:432.2pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">of their body weight</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [57]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">. Three studies did not speci</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">cally mention</span></p>
<p style="top:442.7pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">the effect of the KCRD on body weight</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [27,54,58]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">.</span></p>
<p style="top:463.6pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOTb83ee1dd.B,serif;font-size:8.1pt">4. Discussion</span></p>
<p style="top:484.5pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOTb92eb7df.I,serif;font-size:8.1pt">4.1. Preclinical studies</span></p>
<p style="top:505.4pt;left:323.5pt;line-height:8.1pt"><span style="font-family:AdvOTb92eb7df.I,serif;font-size:8.1pt">In vitro</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">, KCRDs improve stress and chemotoxicity resistance of</span></p>
<p style="top:515.9pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">normal brain cells</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [30,32]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">, and sensitize glioma cells to chemo-</span></p>
<p style="top:526.3pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">therapeutics</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [29,32,33]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">. Published</span><span style="font-family:AdvOTb92eb7df.I,serif;font-size:8.1pt"> in vivo</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> studies suggest that</span></p>
<p style="top:536.8pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">KCRDs (and particularly caloric restricted forms) reduce tumor</span></p>
<p style="top:547.3pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">growth. This is in line with two meta-analyses of preclinical studies</span></p>
<p style="top:557.8pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">on effects of KCRDs in brain and non-brain tumors</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [59,60]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">. How-</span></p>
<p style="top:568.2pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ever, survival improved in only a small majority of studies included</span></p>
<p style="top:578.7pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">in our review. Positive effects increased when KCRDs were used</span></p>
<p style="top:589.1pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">concomitantly with other treatment modalities</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [25,29,33,37</span><span style="font-family:AdvPS44A44B,serif;font-size:8.1pt;color:#0a7fac">e</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac">39]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">.</span></p>
<p style="top:599.6pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">Because of these synergistic effects, we recommend to use KCRDs</span></p>
<p style="top:610.0pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">concomitantly with chemoradiation in future studies. Although</span></p>
<p style="top:620.5pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">bevacizumab is commonly prescribed in the treatment of malig-</span></p>
<p style="top:630.9pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">nant gliomas, recent randomized controlled trials have shown no</span></p>
<p style="top:641.4pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">bene</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">t for overall survival</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [61,62]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">; given this absence of proof for</span></p>
<p style="top:651.9pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ef</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">cacy, the role of bevacizumab, combined with KCRDs or other</span></p>
<p style="top:662.4pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">emerging therapies, remains to be determined. Regarding the</span></p>
<p style="top:672.8pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">combination of a KCRD and radiotherapy</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [37]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">, it is unclear whether</span></p>
<p style="top:683.3pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">the synergistic effect is based on the metabolic effects of the KCRD,</span></p>
<p style="top:693.8pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">or on the radiosensitizing inhibition of HDAC by the KCRD</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [13]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">.</span></p>
<p style="top:704.2pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">Future studies that combine these interventions should include</span></p>
<p style="top:714.7pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">measurements of appropriate markers (e.g., histone acetylation).</span></p>
<p style="top:725.1pt;left:323.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">In contrast to these mainly positive results, Flavahan et al. re-</span></p>
<p style="top:735.6pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ported shorter median survival</span><span style="font-family:AdvOTb92eb7df.I,serif;font-size:8.1pt"> in vivo</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> if tumor cells were</span></p>
<p style="top:47.8pt;left:221.2pt;line-height:6.4pt"><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.4pt">L. Noorlag et al. / Clinical Nutrition 38 (2019) 1986</span><span style="font-family:AdvPS44A44B,serif;font-size:6.4pt">e</span><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.4pt">1994</span></p>
<p style="top:47.8pt;left:548.6pt;line-height:6.4pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.4pt">1991</span></p>


<p style="top:66.1pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">previously exposed to low glucose conditions</span><span style="font-family:AdvOTb92eb7df.I,serif;font-size:8.1pt"> in vitro</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [28]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">, possibly</span></p>
<p style="top:76.6pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">due to the preferential survival of BTICs and the acquisition of BTIC</span></p>
<p style="top:87.0pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">characteristics</span></p>
<p style="top:87.0pt;left:93.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">by</span></p>
<p style="top:87.0pt;left:109.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">non-BTICs.</span></p>
<p style="top:87.0pt;left:157.0pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">BTICs</span></p>
<p style="top:87.0pt;left:184.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">are</span></p>
<p style="top:87.0pt;left:203.1pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">hypothesized</span></p>
<p style="top:87.0pt;left:260.4pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">to</span></p>
<p style="top:87.0pt;left:274.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">be</span></p>
<p style="top:97.5pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">responsible for tumor recurrence</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [63]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">, and are relatively resistant</span></p>
<p style="top:108.0pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">to radiotherapy</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [64]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> and chemotherapy</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [65]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">. This is in line with a</span></p>
<p style="top:118.4pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">study on epithelial cancer cells that found that the ketone body</span><span style="font-family:AdvP3F4C13,serif;font-size:8.7pt"> b</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">-</span></p>
<p style="top:128.9pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">hydroxybutyrate stimulates tumor growth</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [66]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">. It is unclear why</span></p>
<p style="top:139.3pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">Flavahan et al.&apos;s</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt"> &#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ndings of shortened survival are so contradictory</span></p>
<p style="top:149.8pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">to most other preclinical studies (showing improved survival).</span></p>
<p style="top:160.2pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">Nevertheless, because of these</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt"> &#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ndings, we recommend to carefully</span></p>
<p style="top:170.7pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">monitor patients on KCRDs in future studies for accelerated tumor</span></p>
<p style="top:181.2pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">growth or the development of a pattern of tumor recurrence with a</span></p>
<p style="top:191.6pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">strong resistance to therapies.</span></p>
<p style="top:202.1pt;left:44.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">We found a trend (P</span><span style="font-family:AdvP4C4E74,serif;font-size:8.1pt"> &#xbc;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> 0.07, Phi</span><span style="font-family:AdvP4C4E74,serif;font-size:8.1pt"> &#xbc;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> 0.57) towards an association</span></p>
<p style="top:212.6pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">between decreased glucose concentrations on the one hand, and</span></p>
<p style="top:223.0pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">reduced tumor growth and improved survival on the other.</span></p>
<p style="top:233.5pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">Decreased glucose seems to be more important than increased</span></p>
<p style="top:243.9pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ketones in generating antitumor effects</span><span style="font-family:AdvOTb92eb7df.I,serif;font-size:8.1pt"> in vivo</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">.</span></p>
<p style="top:254.4pt;left:44.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">The preclinical studies had multiple limitations. Firstly, un-</span></p>
<p style="top:264.8pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">common chemotherapeutic agents were used</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [29,32]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">. To increase</span></p>
<p style="top:275.3pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">the validity of</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt"> &#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ndings, we recommend that the selection of che-</span></p>
<p style="top:285.8pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">motherapeutics for future studies are based on proven ef</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">cacy for</span></p>
<p style="top:296.2pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">gliomas</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [3,4,67]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">. Secondly, multiple studies used subcutaneous</span></p>
<p style="top:306.7pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">glioma models</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [25,26,29,33,42,52]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">. However, brain tumors are</span></p>
<p style="top:317.2pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">located in a speci</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">c microenvironment, isolated from the normal</span></p>
<p style="top:327.6pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">circulation by the blood</span><span style="font-family:AdvPS44A44B,serif;font-size:8.1pt">e</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">brain barrier. Therefore, we recommend</span></p>
<p style="top:338.1pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">to use only intracerebral models in future studies. In the study of</span></p>
<p style="top:348.6pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">Safdie et al., tumor growth was not reduced and survival not</span></p>
<p style="top:359.0pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">improved with temozolomide or radiotherapy alone</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [33]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">, even</span></p>
<p style="top:369.5pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">though these therapies have proven ef</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">cacy</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [3,4]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">. Therefore, one</span></p>
<p style="top:379.9pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">could doubt the validity of these</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt"> &#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ndings. Moreover, translation of</span></p>
<p style="top:390.4pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">preclinical</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt"> &#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ndings into the clinical practice could be dif</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">cult,</span></p>
<p style="top:400.8pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">particularly for STS, given its questionable applicability. This is not</span></p>
<p style="top:411.3pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">addressed in the speci</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">c studies. In general, neutral and negative</span></p>
<p style="top:421.8pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">animal studies may be more prone to publication bias</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [68]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">, which</span></p>
<p style="top:432.2pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">may cause an overestimation of the positive effects of KCRDs. We</span></p>
<p style="top:442.7pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">cannot exclude such an overestimation in our review, although two</span></p>
<p style="top:453.2pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">meta-analyses of preclinical studies in broader oncological</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt"> &#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">elds</span></p>
<p style="top:463.6pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">converge with our</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt"> &#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ndings</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [59,60]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">.</span></p>
<p style="top:484.5pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOTb92eb7df.I,serif;font-size:8.1pt">4.2. Molecular-biological pathways and mechanisms</span></p>
<p style="top:505.4pt;left:44.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">Glioma cells seemed to have a lesser expression and function of</span></p>
<p style="top:515.9pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ketolytic enzymes</span><span style="font-family:AdvOTb92eb7df.I,serif;font-size:8.1pt"> in vitro</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> and</span><span style="font-family:AdvOTb92eb7df.I,serif;font-size:8.1pt"> in vivo</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [30,35,42]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">, although this was</span></p>
<p style="top:526.3pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">contradicted by the</span><span style="font-family:AdvOTb92eb7df.I,serif;font-size:8.1pt"> in vivo</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> results of one study</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [35]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">. Use of other</span></p>
<p style="top:536.8pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">glioma cell lines and models may explain these differences. In the</span></p>
<p style="top:547.3pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">future, screening for the presence of ketolytic enzymes may be</span></p>
<p style="top:557.8pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">useful to select patients will bene</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">t most from KCRDs.</span></p>
<p style="top:568.2pt;left:44.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">Multiple pathways are in</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb02;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">uenced by KCRDs, such as the PTEN/</span></p>
<p style="top:578.7pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">Akt/TSC2</span></p>
<p style="top:578.7pt;left:75.6pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">pathway,</span></p>
<p style="top:578.7pt;left:118.3pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">AMPK-TSC2-mTOR</span></p>
<p style="top:578.7pt;left:197.3pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">pathway</span></p>
<p style="top:578.7pt;left:238.3pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">and</span></p>
<p style="top:578.7pt;left:260.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">NF-kB</span></p>
<p style="top:589.1pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">pathway</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [31,41,49,52]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">. These</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt"> &#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ndings provide insights in the</span></p>
<p style="top:599.6pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">molecular-biological effects of KCRDs. The study of Lussier et al.</span></p>
<p style="top:610.0pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac">[43]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> suggests that KCRDs may have an effect on the glioma-</span></p>
<p style="top:620.5pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">mediated immune suppression, which warrants future studies</span></p>
<p style="top:631.0pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">and con</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">rmation in humans.</span></p>
<p style="top:651.9pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOTb92eb7df.I,serif;font-size:8.1pt">4.3. Clinical studies</span></p>
<p style="top:672.8pt;left:44.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">Overall, KCRDs seem to be safe and feasible in the preliminary</span></p>
<p style="top:683.3pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">clinical data to date, but ef</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">cacy data are scarce and of low meth-</span></p>
<p style="top:693.8pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">odological quality with high risk of bias. Causality cannot be</span></p>
<p style="top:704.2pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">examined with clinical abstracts and case reports, and their positive</span></p>
<p style="top:714.7pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">results were not reproduced in two small prospective cohort</span></p>
<p style="top:725.1pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">studies</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [39,54]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">. In the retrospective cohort study, however, the PFS</span></p>
<p style="top:735.6pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">seemed to be improved with the KD (10 months)</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [53]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">, compared</span></p>
<p style="top:66.1pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">with standard treatments (6.9 months)</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [3]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">. However, no statistical</span></p>
<p style="top:76.5pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">analysis was performed on these two groups, and therefore no</span></p>
<p style="top:87.0pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">formal conclusion can be drawn.</span></p>
<p style="top:97.5pt;left:313.7pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">Another source of bias is the possibility of treatment-induced</span></p>
<p style="top:108.0pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">necrosis (TIN, also often referred to as pseudoprogression or radi-</span></p>
<p style="top:118.4pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ation necrosis), a phenomenon that mimics progressive or recur-</span></p>
<p style="top:128.9pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">rent tumor on imaging and is commonly mistaken to be tumor</span></p>
<p style="top:139.3pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">recurrence</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [69]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">. Almost all patients in the clinical studies under-</span></p>
<p style="top:149.8pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">went radiotherapy, either before or concomitantly with a KCRD,</span></p>
<p style="top:160.2pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">which may have led to inclusion of recurrent gliomas that actually</span></p>
<p style="top:170.7pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">were TIN. This was not discussed by any of the studies. Also, KCRDs</span></p>
<p style="top:181.1pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">may alter the incidence of TIN due to alterations in the VEGF</span></p>
<p style="top:191.6pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">signaling pathway, which complicates the comparison of PFS data</span></p>
<p style="top:202.1pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">with historic controls.</span></p>
<p style="top:212.6pt;left:313.7pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">In addition,</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt"> &#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ve clinical studies administered KCRDs concomi-</span></p>
<p style="top:223.0pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">tantly with chemotherapy</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [53,55,56,58]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> or bevacizumab</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [54]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">.</span></p>
<p style="top:233.5pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">Therefore, the respective effects of both treatment modalities</span></p>
<p style="top:243.9pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">cannot be assessed accurately from these uncontrolled studies.</span></p>
<p style="top:254.4pt;left:313.7pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">In the majority of the clinical studies, blood and urine ketone</span></p>
<p style="top:264.8pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">concentrations did not reach the reference values recommended by</span></p>
<p style="top:275.3pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">a Dutch guideline for use of a KD in pediatric refractory epilepsy</span></p>
<p style="top:285.8pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac">[22]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">, possibly due to the unrestricted nature of the KCRDs</span></p>
<p style="top:296.2pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac">[39,53</span><span style="font-family:AdvPS44A44B,serif;font-size:8.1pt;color:#0a7fac">e</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac">55,58]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">, administration of corticosteroids</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [39,53,54,58]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">, and</span></p>
<p style="top:306.7pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">the lack of treatment by a registered dietician</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [27,39,53,55,56]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">.</span></p>
<p style="top:317.2pt;left:313.7pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">The classic KD, as used in pediatric refractory epilepsy, is poorly</span></p>
<p style="top:327.6pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">tolerated, due to unpalatability and gastrointestinal adverse effects</span></p>
<p style="top:338.1pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac">[14]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">. In two studies with advanced malignancies (not gliomas),</span></p>
<p style="top:348.6pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">however, KCRDs was well-tolerated in the majority of the patients</span></p>
<p style="top:359.0pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac">[70]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> and did not cause serious adverse effects</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [70,71]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">, besides</span></p>
<p style="top:369.5pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">weight loss of on average 4%</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [71]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> or less</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [70]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">, which was considered</span></p>
<p style="top:379.9pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">harmless</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [71]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">. In a case report of a boy with a grade I astrocytoma</span></p>
<p style="top:390.4pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">(which is not a high-grade glioma</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [1]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">, and therefore not included in</span></p>
<p style="top:400.8pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">this review) on diverse KCRDs, quality of life, neurological and</span></p>
<p style="top:411.3pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">endocrine functions improved while his tumor remained stable</span></p>
<p style="top:421.7pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac">[72,73]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">. Except for grade II fatigue in one patient</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [53]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">, no serious</span></p>
<p style="top:432.2pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">adverse effects were reported in the discussed studies. Weight loss</span></p>
<p style="top:442.7pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">due to KCRDs was absent</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [55]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> or considered minimal</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [39,53,57]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">,</span></p>
<p style="top:453.2pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">except for one patient with a 20% body weight reduction, but</span></p>
<p style="top:463.6pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">nevertheless a Karnofsky performance status of 100%</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [56]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">. Four</span></p>
<p style="top:474.1pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">patients found the KD intolerable</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [39,54]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">, and felt it reduced their</span></p>
<p style="top:484.5pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">quality of life</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [39]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">.</span></p>
<p style="top:495.0pt;left:313.7pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">The selection of the optimal KCRD should not only be based on</span></p>
<p style="top:505.4pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ef</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">cacy, but also on safety, feasibility, and the effect on quality of</span></p>
<p style="top:515.9pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">life. In addition, body weight should be maintained, since weight</span></p>
<p style="top:526.4pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">loss and malnutrition in cancer patients are associated with a poor</span></p>
<p style="top:536.8pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">response to therapies, more adverse effects and complications,</span></p>
<p style="top:547.3pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">short median survival and poor quality of life</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [74]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">. Therefore, it is</span></p>
<p style="top:557.8pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">recommended not to use caloric restricted diets in cancer patients</span></p>
<p style="top:568.2pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">at risk for malnutrition</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [75]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">. The selection of the optimal patient,</span></p>
<p style="top:578.7pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">however, is equally important.</span></p>
<p style="top:599.6pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOTb83ee1dd.B,serif;font-size:8.1pt">5. Conclusions</span></p>
<p style="top:620.5pt;left:313.7pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">The role of KCRDs as (adjunct) treatment modalities for malig-</span></p>
<p style="top:631.0pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">nant gliomas is supported by the majority of published preclinical</span></p>
<p style="top:641.4pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">studies to date. However, because of the paucity of clinical data,</span></p>
<p style="top:651.9pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">conclusions on ef</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">cacy and quality of life cannot be drawn. Data on</span></p>
<p style="top:662.4pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">adverse effects, such as weight loss, suggest that KCRDs are safe and</span></p>
<p style="top:672.8pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">feasible in cancer patients, but these data are preliminary. Effects</span></p>
<p style="top:683.3pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">on nutritional status, body composition and physical functioning</span></p>
<p style="top:693.8pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">are largely unknown. Therefore, KCRDs in gliomas should be</span></p>
<p style="top:704.2pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">regarded as experimental, and should preferably only be imple-</span></p>
<p style="top:714.7pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">mented in the context of clinical studies.</span></p>
<p style="top:725.1pt;left:313.7pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">The time is right for multidisciplinary prospective clinical</span></p>
<p style="top:735.6pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">studies that will examine whether KCRDs have clinically relevant</span></p>
<p style="top:47.8pt;left:211.5pt;line-height:6.4pt"><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.4pt">L. Noorlag et al. / Clinical Nutrition 38 (2019) 1986</span><span style="font-family:AdvPS44A44B,serif;font-size:6.4pt">e</span><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.4pt">1994</span></p>
<p style="top:47.8pt;left:32.8pt;line-height:6.4pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.4pt">1992</span></p>


<p style="top:66.1pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">effects for glioma patients. As of February 18, 2018, 11 prospective</span></p>
<p style="top:76.6pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">clinical studies are registered in</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> ClinicalTrials.gov</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> and recruiting</span></p>
<p style="top:87.0pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">glioma patients for (adjunct) treatment with KCRDs. In addition to</span></p>
<p style="top:97.5pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">the above recommendations, new clinical studies should system-</span></p>
<p style="top:108.0pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">atically report effects on blood glucose and ketone concentrations,</span></p>
<p style="top:118.4pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">body weight, nutritional status, body composition, physical func-</span></p>
<p style="top:128.9pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">tioning, tumor growth, survival and quality of life. The latter should</span></p>
<p style="top:139.3pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">be a leading factor, since the treatment of gliomas to date is palli-</span></p>
<p style="top:149.8pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ative in nature. Inclusion of patients should be based on a modern</span></p>
<p style="top:160.2pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">classi</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">cation</span></p>
<p style="top:160.2pt;left:97.6pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">of</span></p>
<p style="top:160.2pt;left:111.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">gliomas</span></p>
<p style="top:160.2pt;left:147.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">that</span></p>
<p style="top:160.2pt;left:169.4pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">comprises</span></p>
<p style="top:160.2pt;left:214.4pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">both</span></p>
<p style="top:160.2pt;left:238.3pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">histology and</span></p>
<p style="top:170.7pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">molecular-biological markers</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> [76]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">. The possibility of TIN should be</span></p>
<p style="top:181.1pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">considered at inclusion and during (radiological) follow-up. Finally,</span></p>
<p style="top:191.6pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">biomarker data should be systematically collected, for analysis on</span></p>
<p style="top:202.1pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">tumor metabolism and the discussed molecular-biological path-</span></p>
<p style="top:212.6pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ways. This could form the basis for future translational research on</span></p>
<p style="top:223.0pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">optimal use of KCRDs, combinations of KCRDs with (future) tar-</span></p>
<p style="top:233.5pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">geted therapies, and the selection of patients who will bene</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">t most</span></p>
<p style="top:243.9pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">from KCRDs. This could lead to a better understanding of the role of</span></p>
<p style="top:254.4pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">KCRDs in the personalized treatment of gliomas.</span></p>
<p style="top:276.4pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOTb83ee1dd.B,serif;font-size:8.1pt">Funding</span></p>
<p style="top:297.3pt;left:54.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">This work was supported by The Ton</span><span style="font-family:AdvTT5843c571,serif;font-size:8.1pt"> &amp;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> Patricia Bohnenn fund</span></p>
<p style="top:307.7pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">for Neuro-oncology.</span></p>
<p style="top:329.7pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOTb83ee1dd.B,serif;font-size:8.1pt">Statement of authorship</span></p>
<p style="top:350.7pt;left:54.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">The authors&apos; contributions were as follows</span><span style="font-family:AdvPS44A44B,serif;font-size:8.1pt"> e</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> All authors</span></p>
<p style="top:361.1pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">contributed to the conception and/or the analysis of the paper; All</span></p>
<p style="top:371.6pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">authors contributed to the writing of the manuscript and approved</span></p>
<p style="top:382.0pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">the</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt"> &#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">nal version; LN performed the data extraction from the</span></p>
<p style="top:392.5pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">selected papers and wrote the</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt"> &#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">rst draft; AK made the</span><span style="font-family:AdvOT863180fb+20,serif;font-size:8.1pt"> &#x2018;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">golden hit</span><span style="font-family:AdvOT863180fb+20,serif;font-size:8.1pt">&#x2019;</span></p>
<p style="top:402.9pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">list; LN and FYV independently performed the selection of ab-</span></p>
<p style="top:413.4pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">stracts; MLB and PAR reviewed the preclinical data; TJS reviewed</span></p>
<p style="top:423.9pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">the data extraction, co-wrote the</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt"> &#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">rst draft and supervised the</span></p>
<p style="top:434.3pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">project.</span></p>
<p style="top:456.3pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOTb83ee1dd.B,serif;font-size:8.1pt">Con</span><span style="font-family:AdvOTb83ee1dd.B+fb,serif;font-size:8.1pt">&#xfb02;</span><span style="font-family:AdvOTb83ee1dd.B,serif;font-size:8.1pt">ict of interest</span></p>
<p style="top:477.3pt;left:54.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">The authors reported no con</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb02;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">icts of interest.</span></p>
<p style="top:499.2pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOTb83ee1dd.B,serif;font-size:8.1pt">Acknowledgements</span></p>
<p style="top:520.1pt;left:54.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">We want to thank S. Brandhorst and Dr. Longo for providing us</span></p>
<p style="top:530.6pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">with additional information on their paper.</span></p>
<p style="top:552.6pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOTb83ee1dd.B,serif;font-size:8.1pt">Appendix A. Supplementary data</span></p>
<p style="top:573.5pt;left:54.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">Supplementary data to this article can be found online at</span></p>
<p style="top:583.9pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac">https://doi.org/10.1016/j.clnu.2018.10.024</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">.</span></p>
<p style="top:605.9pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOTb83ee1dd.B,serif;font-size:8.1pt">References</span></p>
<p style="top:625.3pt;left:45.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">[1]</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, et al. The</span></p>
<p style="top:633.3pt;left:58.4pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">2007 WHO classi</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:6.5pt;color:#0a7fac">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">cation of tumours of the central nervous system. Acta</span></p>
<p style="top:641.3pt;left:58.4pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">Neuropathol 2007;114:97</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt;color:#0a7fac">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">109</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:649.2pt;left:45.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">[2]</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Ostrom QT, Gittleman H, Liao P, Rouse C, Chen Y, Dowling J, et al. CBTRUS</span></p>
<p style="top:657.2pt;left:58.4pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">statistical report: primary brain and central nervous system tumors diagnosed</span></p>
<p style="top:665.1pt;left:58.4pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">in the United States in 2007-2011. Neuro Oncol 2014;16:iv1</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt;color:#0a7fac">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">63</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:673.1pt;left:45.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">[3]</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Stupp R, Mason WP, Van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, et al.</span></p>
<p style="top:681.1pt;left:58.4pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.</span></p>
<p style="top:689.1pt;left:58.4pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">N Engl J Med 2005;352:987</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt;color:#0a7fac">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">96</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:697.1pt;left:45.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">[4]</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Omuro A, DeAngelis LM. Glioblastoma and other malignant gliomas: a clinical</span></p>
<p style="top:705.0pt;left:58.4pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">review. J Am Med Assoc 2013;310:1842</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt;color:#0a7fac">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">50</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:713.0pt;left:45.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">[5]</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> American Cancer Society. Cancer facts</span><span style="font-family:AdvTT5843c571,serif;font-size:6.5pt;color:#0a7fac"> &amp;</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:6.5pt;color:#0a7fac"> &#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">gures 2014. Atlanta: American</span></p>
<p style="top:720.9pt;left:58.4pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">Cancer Society, Inc.; 2014</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:728.9pt;left:45.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">[6]</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC, et al.</span></p>
<p style="top:736.9pt;left:58.4pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">Effects of radiotherapy with concomitant and adjuvant temozolomide versus</span></p>
<p style="top:66.2pt;left:327.4pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">radiotherapy alone on survival in glioblastoma in a randomised phase III</span></p>
<p style="top:74.2pt;left:327.4pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 2009;10:459</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt;color:#0a7fac">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">66</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:82.2pt;left:314.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">[7]</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Warburg O, Wind F, Negelein E. The metabolism of tumors in the body. J Gen</span></p>
<p style="top:90.2pt;left:327.4pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">Physiol 1927;8:519</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt;color:#0a7fac">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">30</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:98.1pt;left:314.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">[8]</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Warburg O. On the origin of cancer cells. Science 1956;123:309</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt;color:#0a7fac">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">14</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:106.1pt;left:314.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">[9]</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Oudard S, Boitier E, Miccoli L, Rousset S, Dutrillaux B, Poupon MF. Gliomas are</span></p>
<p style="top:114.1pt;left:327.4pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">driven by glycolysis: putative roles of hexokinase, oxidative phosphorylation</span></p>
<p style="top:122.0pt;left:327.4pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">and mitochondrial ultrastructure. Anticancer Res 1997;17:1903</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt;color:#0a7fac">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">11</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:130.0pt;left:311.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">[10]</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Chang HT, Olson LK, Schwartz KA. Ketolytic and glycolytic enzymatic</span></p>
<p style="top:137.9pt;left:327.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">expression pro</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:6.5pt;color:#0a7fac">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">les in malignant gliomas: implication for ketogenic diet</span></p>
<p style="top:145.9pt;left:327.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">therapy. Nutr Metab 2013;10:47</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:153.9pt;left:311.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">[11]</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Lu CL, Qin L, Liu HC, Candas D, Fan M, Li JJ. Tumor cells switch to mitochondrial</span></p>
<p style="top:161.9pt;left:327.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">oxidative phosphorylation under radiation via mTOR-mediated hexokinase II</span></p>
<p style="top:169.9pt;left:327.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">inhibition - a Warburg-reversing effect. PloS One 2015;10:e0121046</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:177.8pt;left:311.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">[12]</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Derr RL, Ye X, Islas MU, Desideri S, Saudek CD, Grossman SA. Association</span></p>
<p style="top:185.8pt;left:327.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">between hyperglycemia and survival in patients with newly diagnosed glio-</span></p>
<p style="top:193.7pt;left:327.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">blastoma. J Clin Oncol 2009;27:1082</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt;color:#0a7fac">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">6</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:201.7pt;left:311.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">[13]</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Newman JC, Verdin E. Ketone bodies as signaling metabolites. Trends Endo-</span></p>
<p style="top:209.7pt;left:327.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">crinol Metabol 2014;25:42</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt;color:#0a7fac">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">52</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:217.7pt;left:311.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">[14]</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Levy RG, Cooper PN, Giri P. Ketogenic diet and other dietary treatments for</span></p>
<p style="top:225.6pt;left:327.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">epilepsy. Cochrane Database Syst Rev 2012;3:CD001903</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:233.6pt;left:311.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">[15]</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Mahoney LB, Denny CA, Seyfriend TN. Caloric restriction in C57BL/6J mice</span></p>
<p style="top:241.6pt;left:327.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">mimics therapeutic fasting in humans. Lipids Health Dis 2006;5:13</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:249.6pt;left:311.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">[16]</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group. Preferred</span></p>
<p style="top:257.5pt;left:327.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">reporting items for systematic reviews and meta-analyses: the PRISMA</span></p>
<p style="top:265.5pt;left:327.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">statement. PLoS Med 2009;6:e1000097</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:273.4pt;left:311.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">[17]</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Seyfried TN, Flores R, Poff AM, D&apos;Agostino DP, Mukherjee P. Metabolic ther-</span></p>
<p style="top:281.4pt;left:327.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">apy: a new paradigm for managing malignant brain cancer. Cancer Lett</span></p>
<p style="top:289.4pt;left:327.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">2015;356:289</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt;color:#0a7fac">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">300</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:297.4pt;left:311.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">[18]</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Woolf EC, Scheck AC. The ketogenic diet for the treatment of malignant gli-</span></p>
<p style="top:305.4pt;left:327.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">oma. J Lipid Res 2015;56:5</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt;color:#0a7fac">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">10</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:313.3pt;left:311.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">[19]</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Maroon J, Bost J, Amos A, Zuccoli G. Restricted calorie ketogenic diet for the</span></p>
<p style="top:321.3pt;left:327.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">treatment of glioblastoma multiforme. J Child Neurol 2013;28:1002</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt;color:#0a7fac">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">8</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:329.2pt;left:311.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">[20]</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Woolf EC, Syed N, Scheck AC. Tumor metabolism, the ketogenic diet and</span><span style="font-family:AdvP3F4C13,serif;font-size:7.0pt;color:#0a7fac"> b</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">-</span></p>
<p style="top:337.2pt;left:327.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">Hydroxybutyrate: novel approaches to adjuvant brain tumor therapy. Front</span></p>
<p style="top:345.2pt;left:327.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">Mol Neurosci 2016;19:122</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:353.2pt;left:311.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">[21]</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Winter SF, Loebel F, Dietrich J. Role of ketogenic metabolic therapy in ma-</span></p>
<p style="top:361.1pt;left:327.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">lignant glioma: a systematic review. Crit Rev Oncol Hematol 2017;112:41</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt;color:#0a7fac">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">58</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:369.1pt;left:311.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">[22]</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Van den Hurk TAM, Van der Louw EJTM. Dietary treatment guideline for the</span></p>
<p style="top:377.1pt;left:327.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">ketogenic diet in children with refractory epilepsy. Evidence-based manual</span></p>
<p style="top:385.0pt;left:327.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">for multidisciplinary treatment. Utrecht: University Medical Center Utrecht,</span></p>
<p style="top:393.0pt;left:327.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">the Department of Nutritional Sciences and Dietetics; 2007</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:401.0pt;left:311.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">[23]</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med</span></p>
<p style="top:408.9pt;left:327.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">1971;285:1182</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt;color:#0a7fac">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">6</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:416.9pt;left:311.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">[24]</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Higgins JP, Altman DG, Sterne JA. Assessing risk of bias in included studies. In:</span></p>
<p style="top:424.9pt;left:327.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">Higgins JP, Green S, editors. Cochrane handbook for systematic reviews of</span></p>
<p style="top:432.9pt;left:327.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">interventions. Version 5.1.0. The Cochrane Collaboration; 2011</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:440.9pt;left:311.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">[25]</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Poff AM, Ari C, Seyfried TN, D&apos;Agostino DP. The ketogenic diet and hyperbaric</span></p>
<p style="top:448.8pt;left:327.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">oxygen therapy prolong survival in mice with systemic metastatic cancer.</span></p>
<p style="top:456.8pt;left:327.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">PloS One 2013;8:e65522</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:464.7pt;left:311.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">[26]</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Poff AM, Ari C, Arnold P, Seyfried TN, D&apos;Agostino DP. Ketone supplementation</span></p>
<p style="top:472.7pt;left:327.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">decreases tumor cell viability and prolongs survival of mice with metastatic</span></p>
<p style="top:480.7pt;left:327.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">cancer. Int J Cancer 2014;135:1711</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt;color:#0a7fac">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">20</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:488.6pt;left:311.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">[27]</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Moore K. Using the restricted ketogenic diet for brain cancer management:</span></p>
<p style="top:496.6pt;left:327.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">comments from neuro-oncologist. In: Seyfried TN, editor. Cancer as a meta-</span></p>
<p style="top:504.6pt;left:327.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">bolic disease: on the origin, management and prevention of cancer. 1st ed.</span></p>
<p style="top:512.6pt;left:327.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">Hoboken (NJ): John Wiley</span><span style="font-family:AdvTT5843c571,serif;font-size:6.5pt;color:#0a7fac"> &amp;</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Sons, Inc.; 2012. p. 397</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt;color:#0a7fac">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">400</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:520.5pt;left:311.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">[28]</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Flavahan WA, Wu Q, Hitomi M, Rahim N, Kim Y, Sloan AE, et al. Brain tumor</span></p>
<p style="top:528.5pt;left:327.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">initiating cells adapt to restricted nutrition through preferential glucose up-</span></p>
<p style="top:536.5pt;left:327.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">take. Nat Neurosci 2013;16:1373</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt;color:#0a7fac">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">82</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:544.4pt;left:311.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">[29]</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Lee C, Raffaghello L, Brandhorst S, Safdie FM, Bianchi G, Martin-Montalvo A,</span></p>
<p style="top:552.4pt;left:327.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">et al. Fasting cycles retard growth of tumors and sensitize a range of cancer</span></p>
<p style="top:560.4pt;left:327.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">cell types to chemotherapy. Sci Transl Med 2012;4:124ra27</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:568.4pt;left:311.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">[30]</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Maurer GD, Brucker DP, B</span><sup><span style="font-family:AdvP4C4E59,serif;font-size:6.5pt;color:#0a7fac">&#x20ac;</span></sup><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">ahr O, Harter PN, Hattingen E, Walenta S, et al.</span></p>
<p style="top:576.3pt;left:327.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">Differential utilization of ketone bodies by neurons and glioma cell lines: a</span></p>
<p style="top:584.3pt;left:327.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">rationale for ketogenic diet as experimental glioma therapy. BMC Canc</span></p>
<p style="top:592.3pt;left:327.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">2011;11:315</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:600.2pt;left:311.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">[31]</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Mukherjee P, Mulrooney TJ, Marsh J, Blair D, Chiles TC, Seyfried TN. Differ-</span></p>
<p style="top:608.2pt;left:327.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">ential effects of energy stress on AMPK phosphorylation and apoptosis in</span></p>
<p style="top:616.1pt;left:327.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">experimental brain tumor and normal brain. Mol Cancer 2008;7:37</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:624.1pt;left:311.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">[32]</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Raffaghello L, Lee C, Safdie FM, Wei M, Madia F, Bianchi G, et al. Starvation-</span></p>
<p style="top:632.1pt;left:327.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">dependent differential stress resistance protects normal but not cancer cells</span></p>
<p style="top:640.1pt;left:327.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">against</span></p>
<p style="top:640.1pt;left:355.0pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">high-dose</span></p>
<p style="top:640.1pt;left:390.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">chemotherapy.</span></p>
<p style="top:640.1pt;left:442.2pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">Proc</span></p>
<p style="top:640.1pt;left:461.0pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">Natl</span></p>
<p style="top:640.1pt;left:479.0pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">Acad</span></p>
<p style="top:640.1pt;left:499.2pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">Sci</span></p>
<p style="top:640.1pt;left:513.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">USA</span></p>
<p style="top:640.1pt;left:531.0pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">2008;105:</span></p>
<p style="top:648.1pt;left:327.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">8215</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt;color:#0a7fac">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">20</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:656.0pt;left:311.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">[33]</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Safdie F, Brandhorst S, Wei M, Wang W, Lee C, Hwang S, et al. Fasting en-</span></p>
<p style="top:664.0pt;left:327.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">hances the response of glioma to chemo- and radiotherapy. PloS One 2012;7:</span></p>
<p style="top:672.0pt;left:327.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">e44603</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:679.9pt;left:311.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">[34]</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Stafford P, Abdelwahab MG, Kim do Y, Preul MC, Rho JM, Scheck AC. The</span></p>
<p style="top:687.9pt;left:327.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">ketogenic diet reverses gene expression patterns and reduces reactive oxygen</span></p>
<p style="top:695.9pt;left:327.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">species levels when used as an adjuvant therapy for glioma. Nutr Metab</span></p>
<p style="top:703.9pt;left:327.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">2010;7:74</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:711.8pt;left:311.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">[35]</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> De Feyter HM, Behar KL, Rao JU, Madden-Hennessey K, Ip KL, Hyder F, et al.</span></p>
<p style="top:719.8pt;left:327.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">A ketogenic diet increases transport and oxidation of ketone bodies in RG2</span></p>
<p style="top:727.8pt;left:327.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">and 9L gliomas without affecting tumor growth. Neuro Oncol 2016;18:</span></p>
<p style="top:735.7pt;left:327.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">1079</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt;color:#0a7fac">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">87</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:47.8pt;left:221.2pt;line-height:6.4pt"><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.4pt">L. Noorlag et al. / Clinical Nutrition 38 (2019) 1986</span><span style="font-family:AdvPS44A44B,serif;font-size:6.4pt">e</span><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.4pt">1994</span></p>
<p style="top:47.8pt;left:548.3pt;line-height:6.4pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.4pt">1993</span></p>


<p style="top:66.2pt;left:32.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">[36]</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Martuscello</span></p>
<p style="top:66.2pt;left:90.0pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">RT,</span></p>
<p style="top:66.2pt;left:104.6pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">Vedam-Mai</span></p>
<p style="top:66.2pt;left:145.2pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">V,</span></p>
<p style="top:66.2pt;left:156.4pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">McCarthy</span></p>
<p style="top:66.2pt;left:191.0pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">DJ,</span></p>
<p style="top:66.2pt;left:204.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">Schmoll</span></p>
<p style="top:66.2pt;left:234.0pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">ME,</span></p>
<p style="top:66.2pt;left:250.7pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">Jundi</span></p>
<p style="top:66.2pt;left:271.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">MA,</span></p>
<p style="top:74.2pt;left:49.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">Louviere CD, et al. A supplemented high-fat low-carbohydrate diet for the</span></p>
<p style="top:82.2pt;left:49.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">treatment of glioblastoma. Clin Cancer Res 2016;22:2482</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt;color:#0a7fac">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">95</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:90.2pt;left:32.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">[37]</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Abdelwahab MG, Fenton KE, Preul MC, Rho JM, Lynch A, Stafford P, et al. The</span></p>
<p style="top:98.1pt;left:49.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">ketogenic diet is an effective adjuvant to radiation therapy for the treatment</span></p>
<p style="top:106.1pt;left:49.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">of malignant glioma. PloS One 2012;7:e36197</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:114.1pt;left:32.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">[38]</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Marsh J, Mukherjee P, Seyfried TN. Drug/diet synergy for managing malignant</span></p>
<p style="top:122.0pt;left:49.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">astrocytoma in mice: 2-deoxy-D-glucose and the restricted ketogenic diet.</span></p>
<p style="top:130.0pt;left:49.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">Nutr Metab 2008 Nov 25;5:33</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:137.9pt;left:32.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">[39]</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Rieger J, B</span><sup><span style="font-family:AdvP4C4E59,serif;font-size:6.5pt;color:#0a7fac">&#x20ac;</span></sup><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">ahr O, Maurer GD, Hattingen E, Franz K, Brucker D, et al. ERGO: a</span></p>
<p style="top:145.9pt;left:49.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">pilot study of ketogenic diet in recurrent glioblastoma. Int J Oncol 2014;44:</span></p>
<p style="top:153.9pt;left:49.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">1843</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt;color:#0a7fac">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">52</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:161.9pt;left:32.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">[40]</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Seyfried TN, Sanderson TM, El-Abbadi MM, McGowan R, Mukherjee P. Role of</span></p>
<p style="top:169.9pt;left:49.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">glucose and ketone bodies in the metabolic control of experimental brain</span></p>
<p style="top:177.8pt;left:49.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">cancer. Br J Cancer 2003;89:1375</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt;color:#0a7fac">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">82</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:185.8pt;left:32.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">[41]</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Woolf EC, Curley KL, Liu Q, Turner GH, Charlton JA, Preul MC, et al. The</span></p>
<p style="top:193.7pt;left:49.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">ketogenic diet alters the hypoxic response and affects expression of proteins</span></p>
<p style="top:201.7pt;left:49.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">associated with angiogenesis, invasive potential and vascular permeability in</span></p>
<p style="top:209.7pt;left:49.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">a mouse glioma model. PloS One 2015;10:e0130357</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:217.7pt;left:32.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">[42]</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Zhou W, Mukherjee P, Kiebish MA, Markis WT, Mantis JG, Seyfried TN. The</span></p>
<p style="top:225.6pt;left:49.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">calorically restricted ketogenic diet, an effective alternative therapy for ma-</span></p>
<p style="top:233.6pt;left:49.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">lignant brain cancer. Nutr Metab 2007;4:5</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:241.6pt;left:32.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">[43]</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Lussier DM, Woolf EC, Johnson JL, Brooks KS, Blattman JN, Scheck AC.</span></p>
<p style="top:249.6pt;left:49.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">Enhanced immunity in a mouse model of malignant glioma is mediated by a</span></p>
<p style="top:257.5pt;left:49.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">therapeutic ketogenic diet. BMC Canc 2016;16:310</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:265.5pt;left:32.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">[44]</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Yokoyama K, Kamata N, Fujimoto R, Tsutsumi S, Tomonari M, Taki M, et al.</span></p>
<p style="top:273.4pt;left:49.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">Increased invasion and matrix metalloproteinase-2 expression by Snail-</span></p>
<p style="top:281.4pt;left:49.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">induced mesenchymal transition in squamous cell carcinomas. Int J Oncol</span></p>
<p style="top:289.4pt;left:49.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">2003;22:891</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt;color:#0a7fac">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">8</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:297.4pt;left:32.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">[45]</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Phillips HS, Kharbanda S, Chen R, Forrest WF, Soriano RH, Wu TD, et al. Mo-</span></p>
<p style="top:305.4pt;left:49.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">lecular subclasses of high-grade glioma predict prognosis, delineate a pattern</span></p>
<p style="top:313.3pt;left:49.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">of disease progression, and resemble stages in neurogenesis. Cancer Cell</span></p>
<p style="top:321.3pt;left:49.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">2006;9:157</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt;color:#0a7fac">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">73</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:329.2pt;left:32.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">[46]</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Jiang YS, Wang FR. Caloric restriction reduces edema and prolongs survival in</span></p>
<p style="top:337.2pt;left:49.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">a mouse glioma model. J Neuro Oncol 2013;114:25</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt;color:#0a7fac">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">32</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:345.2pt;left:32.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">[47]</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Mukherjee P, Abate LE, Seyfried TN. Antiangiogenic and proapoptotic effects</span></p>
<p style="top:353.1pt;left:49.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">of dietary restriction on experimental mouse and human brain tumors. Clin</span></p>
<p style="top:361.1pt;left:49.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">Cancer Res 2004;10:5622</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt;color:#0a7fac">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">9</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:369.1pt;left:32.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">[48]</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Mukherjee P, El-Abbadi MM, Kasperzyk JL, Ranes MK, Seyfried TN. Dietary</span></p>
<p style="top:377.1pt;left:49.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">restriction reduces angiogenesis and growth in an orthotopic mouse brain</span></p>
<p style="top:385.0pt;left:49.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">tumour model. Br J Cancer 2002;86:1615</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt;color:#0a7fac">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">21</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:393.0pt;left:32.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">[49]</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Mulrooney TJ, Marsh J, Urits I, Seyfried TN, Mukherjee P. In</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:6.5pt;color:#0a7fac">&#xfb02;</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">uence of caloric</span></p>
<p style="top:401.0pt;left:49.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">restriction on constitutive expression of NF-</span><span style="font-family:AdvP3F4C13,serif;font-size:7.0pt;color:#0a7fac">k</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">B in an experimental mouse</span></p>
<p style="top:408.9pt;left:49.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">astrocytoma. PloS One 2011;6:e18085</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:416.9pt;left:32.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">[50]</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Shelton LM, Huysentruyt LC, Mukherjee P, Seyfried TN. Calorie restriction as</span></p>
<p style="top:424.9pt;left:49.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">an anti-invasive therapy for malignant brain cancer in the VM mouse. ASN</span></p>
<p style="top:432.9pt;left:49.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">Neuro 2010;2:e00038</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:440.9pt;left:32.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">[51]</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Urits I, Mukherjee P, Meidenbauer J, Seyfried TN. Dietary restriction promotes</span></p>
<p style="top:448.8pt;left:49.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">vessel maturation in a mouse astrocytoma. J Oncol 2012;2012:264039</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:456.8pt;left:32.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">[52]</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Marsh J, Mukherjee P, Seyfried TN. Akt-dependent proapoptotic effects of</span></p>
<p style="top:464.7pt;left:49.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">dietary restriction on late-stage management of a phosphatase and tensin</span></p>
<p style="top:472.7pt;left:49.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">homologue/tuberous sclerosis complex 2-de</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:6.5pt;color:#0a7fac">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">cient mouse astrocytoma. Clin</span></p>
<p style="top:480.7pt;left:49.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">Cancer Res 2008;14:7751</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt;color:#0a7fac">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">62</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:488.6pt;left:32.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">[53]</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Champ CE, Palmer JD, Volek JS, Werner-Wasik M, Andrews DW, Evans JJ, et al.</span></p>
<p style="top:496.6pt;left:49.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">Targeting metabolism with a ketogenic diet during the treatment of glio-</span></p>
<p style="top:504.6pt;left:49.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">blastoma multiforme. J Neuro Oncol 2014;117:125</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt;color:#0a7fac">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">31</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:512.6pt;left:32.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">[54]</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Artzi M, Liberman G, Vaisman N, Bokstein F, Vitinshtein F, Aizenstein O, et al.</span></p>
<p style="top:520.5pt;left:49.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">Changes in cerebral metabolism during ketogenic diet in patients with pri-</span></p>
<p style="top:528.5pt;left:49.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">mary brain tumors: 1H-MRS study. J Neuro Oncol 2017;132:267</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt;color:#0a7fac">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">75</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:536.5pt;left:32.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">[55]</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Nebeling LC, Miraldi F, Shurin SB, Lerner E. Effects of a ketogenic diet on tumor</span></p>
<p style="top:544.4pt;left:49.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">metabolism and nutritional status in pediatric oncology patients: two case</span></p>
<p style="top:552.4pt;left:49.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">reports. J Am Coll Nutr 1995;14:202</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt;color:#0a7fac">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">8</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:560.4pt;left:32.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">[56]</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Zuccoli G, Marcello N, Pisanello A, Servadei F, Vaccaro S, Mukherjee P, et al.</span></p>
<p style="top:568.4pt;left:49.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">Metabolic management of glioblastoma multiforme using standard therapy</span></p>
<p style="top:576.3pt;left:49.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">together with a restricted ketogenic diet: case report. Nutr Metab 2010;7:33</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:66.2pt;left:301.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">[57]</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Schwartz K, Chang HT, Nikolai M, Pernicone J, Rhee S, Olson K, et al. Treatment</span></p>
<p style="top:74.2pt;left:318.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">of glioma patients with ketogenic diets: report of two cases treated with an</span></p>
<p style="top:82.2pt;left:318.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">IRB-approved energy-restricted ketogenic diet protocol and review of the</span></p>
<p style="top:90.2pt;left:318.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">literature. Cancer Metabol 2015;3:3</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:98.1pt;left:301.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">[58]</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Shen V, Tran L, Brown J. Use of a ketogenic diet as a complimentary metabolic</span></p>
<p style="top:106.1pt;left:318.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">therapy during chemo-radiation therapy in a 7 year old female with glio-</span></p>
<p style="top:114.1pt;left:318.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">blastoma. Neuro Oncol 2016;18:iii54</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:122.0pt;left:301.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">[59]</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Lv M, Zhu X, Wang H, Wang F, Guan W. Roles of caloric restriction, ketogenic</span></p>
<p style="top:130.0pt;left:318.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">diet and intermittent fasting during initiation, progression and metastasis of</span></p>
<p style="top:137.9pt;left:318.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">cancer in animal models: a systematic review and meta-analysis. PloS One</span></p>
<p style="top:145.9pt;left:318.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">2014;9:e115147</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:153.9pt;left:301.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">[60]</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Klement RJ, Champ CE, Otto C, K</span><sup><span style="font-family:AdvP4C4E59,serif;font-size:6.5pt;color:#0a7fac">&#x20ac;</span></sup><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">ammerer U. Anti-tumor effects of ketogenic</span></p>
<p style="top:161.9pt;left:318.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">diets in mice: a meta-analysis. PloS One 2016;11:e0155050</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:169.9pt;left:301.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">[61]</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Wick W, Gorlia T, Bendszus M, Taphoorn M, Sahm F, Harting I, et al. Lomustine</span></p>
<p style="top:177.8pt;left:318.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">and bevacizumab in progressive glioblastoma. N Engl J Med 2017;377:</span></p>
<p style="top:185.8pt;left:318.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">1954</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt;color:#0a7fac">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">63</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:193.7pt;left:301.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">[62]</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Chinot OL, Wick W, Mason W, Henriksson R, Saran F, Nishikawa R, et al.</span></p>
<p style="top:201.7pt;left:318.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glio-</span></p>
<p style="top:209.7pt;left:318.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">blastoma. N Engl J Med 2014;370:709</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt;color:#0a7fac">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">22</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:217.7pt;left:301.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">[63]</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Chen J, Li Y, Yu TS, McKay RM, Burns DK, Kernie SG, et al. A restricted cell</span></p>
<p style="top:225.6pt;left:318.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">population propagates glioblastoma growth after chemotherapy. Nature</span></p>
<p style="top:233.6pt;left:318.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">2012;488:522</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt;color:#0a7fac">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">6</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:241.6pt;left:301.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">[64]</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland AB, et al. Glioma stem</span></p>
<p style="top:249.6pt;left:318.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">cells promote radioresistance by preferential activation of the DNA damage</span></p>
<p style="top:257.5pt;left:318.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">response. Nature 2006;444:756</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt;color:#0a7fac">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">60</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:265.5pt;left:301.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">[65]</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Eramo A, Ricci-Vitiani L, Zeuner A, Pallini R, Lotti F, Sette G, et al. Chemo-</span></p>
<p style="top:273.4pt;left:318.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">therapy resistance of glioblastoma stem cells. Cell Death Differ 2006;13:</span></p>
<p style="top:281.4pt;left:318.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">1238</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt;color:#0a7fac">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">41</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:289.4pt;left:301.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">[66]</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Bonuccelli G, Tsirigos A, Whitaker-Menezes D, Pavlides S, Pestell RG,</span></p>
<p style="top:297.4pt;left:318.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">Chiavarina B, et al. Ketones and lactate</span><span style="font-family:AdvOT863180fb+20,serif;font-size:6.5pt;color:#0a7fac"> &#x201c;</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">fuel</span><span style="font-family:AdvOT863180fb+20,serif;font-size:6.5pt;color:#0a7fac">&#x201d;</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> tumor growth and metastasis:</span></p>
<p style="top:305.4pt;left:318.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">evidence that epithelial cancer cells use oxidative mitochondrial metabolism.</span></p>
<p style="top:313.3pt;left:318.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">Cell Cycle 2010;9:3506</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt;color:#0a7fac">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">14</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:321.3pt;left:301.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">[67]</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Van den Bent MJ, Brandes AA, Taphoorn MJ, Kros JM, Kouwenhoven MC,</span></p>
<p style="top:329.2pt;left:318.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">Delattre JY, et al. Adjuvant procarbazine, lomustine, and vincristine chemo-</span></p>
<p style="top:337.2pt;left:318.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">therapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-</span></p>
<p style="top:345.2pt;left:318.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">up of EORTC brain tumor group study 26951. J Clin Oncol 2013;31:344</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt;color:#0a7fac">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">50</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:353.2pt;left:301.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">[68]</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Van der Worp HB, Howells DW, Sena ES, Porritt MJ, Rewell S, O&apos;Collins V, et al.</span></p>
<p style="top:361.1pt;left:318.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">Can animal models of disease reliably inform human studies? PLoS Med</span></p>
<p style="top:369.1pt;left:318.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">2010;7:e1000245</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:377.1pt;left:301.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">[69]</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Brandsma D, Stalpers L, Taal W, Sminia P, Van den Bent MJ. Clinical features,</span></p>
<p style="top:385.0pt;left:318.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">mechanisms, and management of pseudoprogression in malignant gliomas.</span></p>
<p style="top:393.0pt;left:318.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">Lancet Oncol 2008;9:453</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt;color:#0a7fac">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">61</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:401.0pt;left:301.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">[70]</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Schmidt M, Pfetzer N, Schwab M, Strauss I, K</span><sup><span style="font-family:AdvP4C4E59,serif;font-size:6.5pt;color:#0a7fac">&#x20ac;</span></sup><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">ammerer U. Effects of a ketogenic</span></p>
<p style="top:408.9pt;left:318.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">diet on the quality of life in 16 patients with advanced cancer: a pilot trial.</span></p>
<p style="top:416.9pt;left:318.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">Nutr Metab 2011;8:54</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:424.9pt;left:301.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">[71]</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Fine EJ, Segal-Isaacson CJ, Feinman RD, Herszkopf S, Romano MC, Tomuta N,</span></p>
<p style="top:432.9pt;left:318.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">et al. Targeting insulin inhibition as a metabolic therapy in advanced cancer: a</span></p>
<p style="top:440.9pt;left:318.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">pilot safety and feasibility dietary trial in 10 patients. Nutrition 2012;28:</span></p>
<p style="top:448.8pt;left:318.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">1028</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt;color:#0a7fac">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">35</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:456.8pt;left:301.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">[72]</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Kalamian M, Zupec-Kania B, Favara BE, Liepa GU. Ketogenic diet as adjunctive</span></p>
<p style="top:464.7pt;left:318.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">therapy for brain tumors. In: The 1st international symposium on the keto-</span></p>
<p style="top:472.7pt;left:318.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">genic diet for epilepsy and other neurological disorders. Barrow Neurological</span></p>
<p style="top:480.7pt;left:318.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">Institute; 2008 [Poster presentation]</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:488.6pt;left:301.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">[73]</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Kalamian M. The ketogenic diet: a viable management strategy for pediatric</span></p>
<p style="top:496.6pt;left:318.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">brain tumors? Ypsilanti, Michigan: The College of Health and Human Services,</span></p>
<p style="top:504.6pt;left:318.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">Eastern Michigan University; 2010 Mar 15 [Thesis]</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:512.6pt;left:301.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">[74]</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Dutch Dieticians Oncology Group. General nutrition and dietary treatment.</span></p>
<p style="top:520.5pt;left:318.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">nation-wide guideline, version: 3.0. Oncoline (a product of Comprehensive</span></p>
<p style="top:528.5pt;left:318.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">Cancer Centre the Netherlands). 2017</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:536.5pt;left:301.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">[75]</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Arends J, Bachmann P, Baracos V, Barthelemy N, Bertz H, Bozzetti F, et al.</span></p>
<p style="top:544.4pt;left:318.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">ESPEN guidelines on nutrition in cancer patients. Clin Nutr 2017;36:11</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt;color:#0a7fac">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">48</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:552.4pt;left:301.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">[76]</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D,</span></p>
<p style="top:560.4pt;left:318.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">Cavenee WK, et al. The 2016 World Health Organization classi</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:6.5pt;color:#0a7fac">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">cation of tu-</span></p>
<p style="top:568.4pt;left:318.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">mors of the central nervous system: a summary. Acta Neuropathol 2016;131:</span></p>
<p style="top:576.3pt;left:318.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">803</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt;color:#0a7fac">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">20</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:47.8pt;left:211.5pt;line-height:6.4pt"><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.4pt">L. Noorlag et al. / Clinical Nutrition 38 (2019) 1986</span><span style="font-family:AdvPS44A44B,serif;font-size:6.4pt">e</span><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.4pt">1994</span></p>
<p style="top:47.8pt;left:32.8pt;line-height:6.4pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.4pt">1994</span></p>

</div>
